Infective dermatitis

L12_INFECT_DERM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L30.3 Cause of death: ICD-10 — L30.3 2 out of 7 registries used, show all original rules.	5020
4. Check minimum number of events None	5020
5. Include endpoints None	5020
6. Filter based on genotype QC (FinnGen only)	4858

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L30
Name in latin: Dermatitis infectiosa

NAME	L12_INFECT_DERM
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L303
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L303
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infective dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38784	18479	20130
Only index persons	35334	17298	18036
Unadjusted period prevalence (%)
Whole population	0.54	0.53	0.56
Only index persons	0.66	0.64	0.69
Median age at first event (years)
Whole population	52.86	51.94	53.63
Only index persons	52.28	51.57	52.96

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4858	2524	2334
Unadjusted period prevalence (%)	0.98	0.90	1.07
Median age at first event (years)	55.07	51.43	59.01

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5020: Matched controls
50200

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E000007, ,

ATC

6.9

315.8

517

820

E000001, ,

ATC

7.3

307.7

2150

4661

D07AA02

ATC

hydrocortisone; topical

4.2

307.7

1053

2965

E000002, ,

ATC

7.1

307.7

1180

2086

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

11.6

307.7

1268

1417

XQ802

NOMESCO Finland

Epicutan test

61.8

307.7

837

162

D07XC01

ATC

betamethasone; topical

4.3

307.7

1040

2845

E000006, ,

ATC

6.6

307.7

700

1204

L30.3

ICD-10 Finland

Infective dermatitis

4503599627370496.0

307.7

5019

197

L30.9

ICD-10 Finland

Dermatitis, unspecified

12.5

307.7

2456

3566

TQW80

NOMESCO Finland

Local dermatologic skincare

24.5

307.7

561

256

D07BC01

ATC

betamethasone and antiseptics; topical

8.2

307.7

1597

2694

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

855

D02AE01

ATC

carbamide; topical

6.4

307.7

662

1156

D07AC13

ATC

mometasone; topical

6.5

307.7

2751

7865

XQ800

NOMESCO Finland

Prick test

6.2

307.7

639

1149

D09AB01

ATC

zinc bandage without supplements; topical

35.2

307.7

542

172

D07AC01

ATC

betamethasone; topical

9.1

307.7

3526

10334

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

307.7

520

D07AD01

ATC

clobetasol; topical

7.4

307.7

1923

3903

D07AB02

ATC

hydrocortisone butyrate; topical

4.4

307.7

2301

8074

D07AB08

ATC

desonide; topical

7.5

307.7

1171

1957

L30.0

ICD-10 Finland

Nummular dermatitis

23.9

307.7

851

426

E000003, ,

ATC

10.3

307.7

581

627

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.4

307.7

1026

1688

D07BA04

ATC

hydrocortisone and antiseptics; topical

6.1

307.7

1012

1997

E0000UV, ,

ATC

8.6

307.7

3668

12086

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

7.7

307.7

1612

2900

D07CC01

ATC

betamethasone and antibiotics; topical

5.4

307.7

1288

3003

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

48.7

307.7

362

H02AB06

ATC

prednisolone; systemic

2.9

294.4

2944

16415

L28.1

ICD-10 Finland

Prurigo nodularis

105.9

279.8

144

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

133.4

258.2

130

L30.8

ICD-10 Finland

Other specified dermatitis

11.4

257.1

274

254

D02AX

ATC

Other emollients and protectives

9.1

250.0

314

365

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

97.8

238.7

124

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

43.0

230.8

138

D05BB02

ATC

acitretin; oral

9.2

227.8

283

324

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.8

219.0

1489

6579

A46

ICD-10 Finland

Erysipelas

3.2

215.1

1059

3914

L20

ICD-10 Finland

Atopic dermatitis

+∞

208.8

199

XQ848

NOMESCO Finland

Dermatological photography

7.7

206.3

299

412

L28.0

ICD-10 Finland

Lichen simplex chronicus

41.7

202.6

122

R06AE07

ATC

cetirizine; oral

2.4

201.6

2481

14411

E000004, ,

ATC

10.1

199.5

230

238

D07AC14

ATC

methylprednisolone aceponate; topical

5.4

191.9

397

783

S87

ICPC

Dermatitis/atopic eczema

9.1

188.9

235

269

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

187.7

179

L40.0

ICD-10 Finland

Psoriasis vulgaris

5.4

186.7

388

768

N05BB01

ATC

hydroxyzine; systemic

4.5

183.9

481

1154

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

81.5

180.5

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

10.7

174.4

192

186

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

350.9

170.3

171

J01DB01

ATC

cefalexin; oral

3.1

160.0

4391

34791

R06AX27

ATC

desloratadine; oral

2.3

148.7

1577

8338

J01FF01

ATC

clindamycin; systemic

2.3

148.7

1601

8519

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

34.2

148.1

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

168.2

140.2

147

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

48.4

139.2

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

7.1

137.4

210

306

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

126.6

121

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

187.6

123.1

128

R06AE09

ATC

levocetirizine; oral

2.6

123.1

841

3615

D05AX52

ATC

calcipotriol, combinations; topical

3.8

122.4

404

1142

J01DA01

ATC

[U] cefalexin

2.0

119.6

3222

23552

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.6

117.7

768

3223

D11AH01

ATC

tacrolimus; topical

169.6

110.8

116

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

106.0

787

3501

L04AX03

ATC

methotrexate; systemic

2.7

103.5

606

2400

D07AB01

ATC

clobetasone; topical

4.8

102.5

236

507

D07XB05

ATC

dexamethasone; topical

5.5

100.8

201

381

L29.9

ICD-10 Finland

Pruritus, unspecified

6.4

98.3

165

265

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

96.4

774

3557

B35.3

ICD-10 Finland

Tinea pedis

3.6

88.2

306

891

S29

ICPC

Skin symptom/complaint other

2.1

86.4

1001

5323

SPAT1263

SPAT

Sampling

1.8

83.7

2135

14686

S97

ICPC

Chronic ulcer skin

3.0

83.3

382

1320

L08.0

ICD-10 Finland

Pyoderma

9.8

81.7

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

80.4

J01DA09

ATC

[U] cefadroxil

1.9

79.4

1374

8366

L04AD01

ATC

ciclosporin; systemic

5.8

78.1

145

257

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

15.9

76.9

J01AA04

ATC

lymecycline; systemic

2.2

76.5

710

3448

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

10.2

75.3

SPAT1301

SPAT

No procedures

1.8

75.1

1588

10254

L50.3

ICD-10 Finland

Dermatographic urticaria

6.3

75.0

128

209

S76

ICPC

Skin infection other

3.1

74.9

339

1161

S21

ICPC

Skin texture symptom/complaint

2.1

71.5

747

3795

J01AA07

ATC

tetracycline; systemic

2.1

70.0

761

3923

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.3

69.3

274

866

SPAT1260

SPAT

Consultation of another employee

2.0

68.5

915

5080

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

68.1

240

705

D06AX01

ATC

fusidic acid; topical

2.4

67.6

519

2319

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

67.4

301

1022

L26

ICD-10 Finland

Exfoliative dermatitis

667.1

67.1

S02

ICPC

Pruritus

3.8

66.4

206

555

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.8

66.3

153

329

J01CF05

ATC

flucloxacillin; systemic

2.8

65.8

362

1378

C03CA01

ATC

furosemide; systemic

1.8

64.0

1415

9175

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.5

63.5

159

365

D11AX14

ATC

[U] tacrolimus

+∞

62.6

R06AX22

ATC

ebastine; oral

2.0

61.6

819

4524

S18

ICPC

Laceration/cut

1.6

61.5

2211

16269

D07CB01

ATC

triamcinolone and antibiotics; topical

4.7

61.1

143

311

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

58.4

2199

16296

S06

ICPC

Rash localized

2.7

57.3

314

1191

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

290.0

56.3

H02AB04

ATC

methylprednisolone; systemic

2.0

55.7

706

3827

B86

ICD-10 Finland

Scabies

4.1

55.5

157

396

D05AX02

ATC

calcipotriol; topical

3.2

55.2

230

749

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.1

55.1

160

SPAT1312

SPAT

General health counselling

1.7

54.8

1528

10465

J04BA02

ATC

dapsone; oral

11.1

54.6

R03AC02

ATC

salbutamol; inhalant

1.6

54.3

2570

19985

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

5.3

53.7

109

210

S88

ICPC

Dermatitis contact/allergic

4.6

53.6

130

291

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

53.5

383

1653

L04AA01

ATC

[U] ciclosporin

5.8

53.5

175

L29.8

ICD-10 Finland

Other pruritus

6.8

53.4

123

D11AH04

ATC

alitretinoin; oral

274.0

53.2

SPAT1310

SPAT

Counselling related to known health issue

1.7

53.2

1515

10416

S01

ICPC

Pain/tenderness of skin

2.8

51.5

266

978

D01AC02

ATC

miconazole; topical

2.3

50.7

406

1840

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

50.5

632

3402

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

10.9

50.4

S99

ICPC

Skin disease other

4.2

50.2

136

332

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

50.1

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

49.1

878

5299

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

48.9

446

2132

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

48.0

570

3011

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

47.6

1854

13655

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

47.3

441

2127

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

47.2

1426

9890

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

47.1

1343

9185

L04AX01

ATC

azathioprine; systemic

2.9

47.0

226

799

UJF32

NOMESCO Finland

Coloscopy

1.7

46.4

1216

8137

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.1

46.4

128

317

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

45.9

L21.0

ICD-10 Finland

Seborrhoea capitis

7.7

45.8

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

5.0

45.5

199

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

451.8

45.3

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

8.7

45.2

L40.9

ICD-10 Finland

Psoriasis, unspecified

4.6

45.2

108

239

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

43.6

364

1676

D01AE15

ATC

terbinafine; topical

2.2

43.4

373

1739

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

43.0

479

2469

N07BA03

ATC

varenicline; oral

2.6

42.6

265

1069

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

42.6

1160

7810

SPAT1153

SPAT

Removal of sutures

1.6

42.5

1470

10478

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

41.4

1923

14599

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

4.4

41.1

102

233

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

40.8

884

5604

L30.4

ICD-10 Finland

Erythema intertrigo

5.4

40.6

150

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

40.4

517

2794

D11AH02

ATC

pimecrolimus; topical

+∞

39.6

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

380.3

38.1

M79.6

ICD-10 Finland

Pain in limb

1.5

38.0

1878

14365

L73.8

ICD-10 Finland

Other specified follicular disorders

5.8

38.0

120

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.9

37.7

112

293

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

37.1

1193

8317

WZC30

NOMESCO Finland

Teaching

1.7

37.0

753

4681

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.0

37.0

171

591

L30

ICD-10 Finland

Other dermatitis

3.6

36.1

121

344

134

Kela drug reimbursment

General erythroderma

10.3

36.0

R06AX13

ATC

loratadine; oral

1.8

35.7

653

3937

SPAT1262

SPAT

Handing over of treatment supplies

1.7

35.6

835

5386

R06.0

ICD-10 Finland

Dyspnoea

1.6

35.5

1188

8344

N02BE01

ATC

paracetamol; systemic, rectal

1.7

35.5

4267

38794

L85.3

ICD-10 Finland

Xerosis cutis

5.6

35.4

121

R60.0

ICD-10 Finland

Localized oedema

1.8

34.9

553

3197

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

34.8

623

3732

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

34.5

1880

14584

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

34.3

490

2742

R02

ICPC

Shortness of breath/dyspnoea

1.8

34.0

581

3434

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

33.7

307

1463

J01DB05

ATC

cefadroxil; oral

2.5

33.6

221

915

J01XC01

ATC

fusidic acid; systemic

4.4

33.6

189

L12.0

ICD-10 Finland

Bullous pemphigoid

8.5

33.5

N02AX02

ATC

tramadol; systemic, rectal

1.4

33.4

1942

15227

L13.0

ICD-10 Finland

Dermatitis herpetiformis

9.8

33.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

32.8

1376

10113

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

32.8

584

3490

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

32.7

767

4940

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

32.7

604

3649

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

32.4

1406

10403

H02AB07

ATC

prednisone; oral

1.7

32.2

590

3554

ZY010

NOMESCO Finland

Hospital outpatient

2.3

31.7

244

1084

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

31.4

1081

7611

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

31.0

212

894

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

30.8

191

769

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

30.6

1011

7048

R4180

NOMESCO Finland

Podiatric therapy

4.2

30.3

196

T90

ICPC

Diabetes non-insulin dependent

1.5

30.3

1074

7602

D01BA02

ATC

terbinafine; oral

1.5

29.9

1144

8226

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.7

29.8

157

583

SPAT1255

SPAT

Intravenous administration of medicine

2.0

29.6

328

1681

L17

ICPC

Foot/toe symptom/complaint

1.5

29.6

1241

9090

A02BC02

ATC

pantoprazole; systemic

1.4

29.5

3108

26847

L13.9

ICD-10 Finland

Bullous disorder, unspecified

8.2

29.5

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

29.2

2708

22863

R50.9

ICD-10 Finland

Fever, unspecified

1.7

29.1

658

4188

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

29.0

969

6766

N03AX12

ATC

[U] gabapentin; oral

1.6

29.0

726

4743

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

28.7

839

5683

R03BB04

ATC

tiotropium bromide; inhalant

1.8

28.7

454

2617

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

28.6

152

567

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

28.6

587

3642

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

28.5

1202

8802

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

28.5

221

986

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

28.4

364

1962

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

28.4

135

475

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

28.2

1103

7952

L40.8

ICD-10 Finland

Other psoriasis

5.5

27.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

27.5

100

300

E0001A1, ,

ATC

3.5

27.4

281

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

27.3

803

5442

D07AC03

ATC

desoximetasone; topical

3.5

27.1

264

C09AA02

ATC

enalapril; systemic

1.5

26.6

842

5798

XQ845

NOMESCO Finland

Dermatoscopy

3.5

26.5

268

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

9.2

26.5

SPAT1254

SPAT

Administration of medicine

1.6

26.4

644

4171

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

26.3

1234

9203

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

26.1

160

641

J01MA14

ATC

moxifloxacin; systemic

1.8

26.1

403

2304

D11AX15

ATC

[U] pimecrolimus

+∞

26.1

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

26.1

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

26.0

604

3866

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

26.0

160

643

J01MA02

ATC

ciprofloxacin; systemic

1.4

26.0

1723

13662

WQ021, ,

NOMESCO Finland

40.3

25.8

ZZA00

NOMESCO Finland

Split skin graft

2.7

25.8

143

546

205

Kela drug reimbursment

Chronic hypertension

1.5

25.7

1148

8476

D05AX03

ATC

calcitriol; topical

3.9

25.6

199

L23

ICD-10 Finland

Allergic contact dermatitis

6.7

25.5

-, ,

ICD-10 Finland

3.0

25.3

113

384

S07

ICPC

Rash generalized

6.3

25.2

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.3

25.1

200

902

N06AX11

ATC

mirtazapine; oral

1.4

25.0

1456

11271

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

25.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

24.8

1976

16111

L04AA06

ATC

mycophenolic acid; systemic

3.2

24.6

301

SPAT1211

SPAT

Application of soft bandage

1.8

24.6

389

2238

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

24.4

382

2193

A10BA02

ATC

metformin; oral

1.4

24.4

1239

9357

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

5.3

24.3

ZXD05

NOMESCO Finland

Urgent procedure

1.4

24.2

1327

10155

C07AB07

ATC

bisoprolol; oral

1.4

24.2

2113

17460

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

24.1

206

956

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

24.1

730

4967

XQ899

NOMESCO Finland

Other assessment of skin

9.7

24.1

N03AX16

ATC

[U] pregabalin

1.5

23.9

990

7188

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

23.9

142

561

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

23.9

1551

12214

L01BA01

ATC

methotrexate; systemic

2.4

23.8

167

713

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

23.8

243

1210

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

23.7

457

2783

WIX00

NOMESCO Finland

Allergy cleanup guidance

87.2

23.7

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

125.6

23.6

J01FA06

ATC

roxithromycin; oral

1.4

23.4

1715

13760

N05AH04

ATC

quetiapine; oral

1.5

23.4

752

5183

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

23.3

324

1792

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

23.0

759

5257

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

22.9

161

688

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

22.8

285

1522

WQ007, ,

NOMESCO Finland

120.6

22.6

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

22.5

257

L01

ICD-10 Finland

Impetigo

3.7

22.4

195

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

22.3

468

2913

J01MA12

ATC

levofloxacin; systemic

1.5

22.2

781

5481

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.2

22.2

N05CF01

ATC

zopiclone; oral

1.4

22.1

1360

10583

AA1AD

NOMESCO Finland

CT of head and brain

1.4

22.1

1154

8735

L27.2

ICD-10 Finland

Dermatitis due to ingested food

62.8

21.8

C03DA01

ATC

spironolactone; oral

1.6

21.8

506

3231

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

21.8

1249

9603

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

5.6

21.8

L28.2

ICD-10 Finland

Other prurigo

18.4

21.7

R96

ICPC

Asthma

1.7

21.7

393

2352

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

21.7

623

4185

J01AA02

ATC

doxycycline; systemic

1.4

21.6

3542

31950

P01AB01

ATC

metronidazole; oral, rectal

1.4

21.5

1670

13479

K02.1

ICD-10 Finland

Caries of dentine

1.3

21.4

2597

22388

SPAT1151

SPAT

Treatment of major wounds

3.6

21.4

192

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

21.4

348

2020

L04AB04

ATC

adalimumab; parenteral

2.8

21.1

107

390

N07BB01

ATC

disulfiram; oral

2.1

21.1

196

942

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.7

20.9

110

409

A10AB05

ATC

insulin aspart; parenteral

1.8

20.9

339

1965

G47.3

ICD-10 Finland

Sleep apnoea

1.4

20.8

985

7314

A03

ICPC

Fever

1.5

20.7

688

4768

A10AE05

ATC

insulin detemir; parenteral

2.0

20.6

244

1281

A02BC03

ATC

lansoprazole; oral

1.4

20.4

1198

9229

OAB50, ,

SPAT

1.9

20.4

256

1369

I50.0

ICD-10 Finland

Congestive heart failure

1.8

20.4

299

1681

J02AC01

ATC

fluconazole; systemic

1.4

20.4

1577

12696

L84

ICD-10 Finland

Corns and callosities

2.3

20.4

159

712

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.8

20.2

101

366

C08CA01

ATC

amlodipine; oral

1.3

20.2

1626

13169

M04AA01

ATC

allopurinol; systemic

1.6

19.9

553

3684

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

19.8

248

1325

-1, ,

NOMESCO Finland

1.4

19.8

1405

11153

N06AX21

ATC

duloxetine; oral

1.6

19.8

476

3065

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

19.8

446

2827

M54.5

ICD-10 Finland

Low back pain

1.4

19.7

1496

11994

R03BA05

ATC

fluticasone; inhalant

1.5

19.7

730

5169

A02BC01

ATC

omeprazole; systemic

1.4

19.7

1143

8783

NHQ40

NOMESCO Finland

Amputation of toe

3.1

19.5

254

SPAT1058

SPAT

PEF monitoring instruction

1.7

19.5

341

2019

WX704

NOMESCO Finland

Intubation

1.7

19.4

352

2106

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

19.4

372

2261

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

19.4

505

3314

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.2

19.2

241

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.6

19.1

108

417

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

7.5

19.1

J02AC02

ATC

itraconazole; systemic

1.5

19.1

714

5063

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.5

18.9

116

466

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

18.8

2935

25989

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

18.8

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.5

18.7

119

487

SPAT1240

SPAT

Therapeutic discussion

1.6

18.6

419

2653

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

18.6

100

377

WXQ24

NOMESCO Finland

UVB/UVA light therapy

100.4

18.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

18.5

176

853

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

18.5

217

1135

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

18.5

100

378

N06AA12

ATC

doxepin; systemic

2.0

18.5

213

1108

R03BA01

ATC

beclometasone; inhalant

1.5

18.4

563

3827

A10AC01

ATC

insulin (human); parenteral

1.7

18.4

321

1900

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

18.4

360

2199

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

18.3

217

1140

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

18.3

2033

17174

J01FA01

ATC

erythromycin; systemic

1.5

18.2

537

3621

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.2

2380

20543

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.4

18.2

130

561

EBA00

NOMESCO Finland

Extraction of tooth

1.3

18.1

1522

12358

L71.9

ICD-10 Finland

Rosacea, unspecified

2.6

18.1

105

411

R53

ICD-10 Finland

Malaise and fatigue

1.4

18.1

964

7288

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

18.0

117

484

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

17.9

401

2534

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

17.9

251

1392

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.8

17.8

144

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

17.8

306

1803

D01AC03

ATC

econazole; topical

1.8

17.8

262

1476

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

17.7

468

3078

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.2

17.7

141

637

R05

ICPC

Cough

1.4

17.7

972

7383

L04AA13

ATC

[U] leflunomide

2.5

17.6

110

446

R03DC03

ATC

montelukast; oral

1.5

17.6

640

4508

B01AB05

ATC

enoxaparin; parenteral

1.3

17.6

1312

10460

XQ801

NOMESCO Finland

Intracutantest

6.3

17.5

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.1

17.5

229

P15

ICPC

Chronic alcohol abuse

2.3

17.4

138

622

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.9

17.4

L50.0

ICD-10 Finland

Allergic urticaria

2.5

17.4

106

425

K08.3

ICD-10 Finland

Retained dental root

1.7

17.4

318

1907

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

17.3

474

3142

N02AA05

ATC

oxycodone; systemic

1.5

17.3

705

5077

UDC00

NOMESCO Finland

Ear microscopy

1.7

17.2

316

1898

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

17.2

177

885

B01AC04

ATC

clopidogrel; oral

1.5

17.2

668

4767

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

17.0

142

654

WQ020, ,

NOMESCO Finland

31.6

17.0

S08

ICPC

Skin colour change

1.9

17.0

221

1197

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

17.0

280

1631

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

17.0

320

1935

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.9

655

4670

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

16.9

318

1922

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.0

16.9

118

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

16.9

284

1664

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

16.8

1359

10947

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

16.8

344

2127

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

16.7

765

5624

KMAK, ,

NOMESCO Finland

1.3

16.7

2209

19013

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

16.7

949

7241

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

16.6

268

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

16.5

3190

28795

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

16.5

348

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

16.4

303

S91

ICPC

Psoriasis

4.0

16.4

116

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

16.4

122

536

WX720

NOMESCO Finland

Own respiration

1.9

16.4

210

1132

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

16.4

375

2383

SPAT1229

SPAT

Assessment of need for aid

1.7

16.3

301

1809

R06AX26

ATC

fexofenadine; oral

1.8

16.3

259

1493

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

16.3

342

2128

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

16.2

332

2051

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

16.2

3174

28663

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

16.2

127

571

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

16.2

277

1631

M25.5

ICD-10 Finland

Pain in joint

1.3

16.1

1291

10377

A10AE04

ATC

insulin glargine; parenteral

1.6

16.1

404

2625

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

7.1

16.1

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

16.1

1524

12538

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

16.1

326

2010

C01CA24

ATC

epinephrine; parenteral

1.8

16.0

222

1227

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

16.0

319

1957

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

16.0

150

724

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

16.0

170

860

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.0

16.0

177

909

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

15.9

443

2948

N06AA09

ATC

amitriptyline; systemic

1.6

15.9

376

2409

P17

ICPC

Tobacco abuse

3.0

15.8

227

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

15.8

324

2002

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

15.8

410

2684

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

15.8

150

728

J46

ICD-10 Finland

Status asthmaticus

2.3

15.7

113

489

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

15.7

959

7395

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.3

15.7

119

528

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

4.8

15.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

15.6

195

1043

A06AD11

ATC

lactulose; oral

1.5

15.6

578

4082

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.7

15.4

308

N05AA02

ATC

levomepromazine; systemic

2.0

15.4

168

858

QDB10, ,

SPAT

2.7

15.4

297

B35.4

ICD-10 Finland

Tinea corporis

3.1

15.4

210

B07.9

ICD-10 Finland

Verruca simplex

2.1

15.3

145

703

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

15.3

888

6790

WX290

NOMESCO Finland

Other blockage of nerve

1.3

15.3

1971

16851

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

15.2

316

1960

D11AH05

ATC

dupilumab; topical

16.1

15.2

A01

ICPC

Pain general/multiple sites

1.6

15.2

358

2291

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

15.2

478

3266

L14

ICPC

Leg/thigh symptom/complaint

1.7

15.1

313

1939

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

15.1

457

3095

N05CD07

ATC

temazepam; oral

1.5

15.1

453

3063

WZC00, ,

SPAT

1.6

15.0

409

2707

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

15.0

178

936

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

15.0

187

1000

J04AB02

ATC

rifampicin; systemic

3.1

15.0

208

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.2

14.9

124

571

SFA30

NOMESCO Finland

Three-surface restoration

1.3

14.9

1782

15077

L50.8

ICD-10 Finland

Other urticaria

2.8

14.9

252

395

Kela drug reimbursment

Dupilumab

15.1

14.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

14.8

1779

15059

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

14.8

354

2275

N05AX08

ATC

risperidone; systemic

1.6

14.7

319

1999

H01

ICPC

Ear pain/earache

1.5

14.7

432

2906

M10.9

ICD-10 Finland

Gout, unspecified

1.7

14.7

277

1675

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.4

14.6

155

J45

ICD-10 Finland

Asthma

1.6

14.5

381

2500

OAB42, ,

SPAT

1.5

14.5

415

2776

R95

ICPC

Chron obstructive pulmonary disease

2.2

14.5

124

578

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

14.5

371

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

14.3

386

N05BA01

ATC

diazepam; systemic, rectal

1.5

14.2

507

3551

L85.89

ICD-10 Finland

Other specified epidermal thickening

19.2

14.2

P01BA02

ATC

hydroxychloroquine; oral

1.6

14.2

311

1955

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

14.1

1100

8778

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

14.1

226

1305

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.9

14.1

237

T78.3

ICD-10 Finland

Angioneurotic oedema

3.0

14.1

205

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

6.7

14.0

K07

ICPC

Swollen ankles/oedema

1.9

14.0

175

937

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.9

1616

13593

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

13.9

105

465

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

13.9

374

2469

H02AB09

ATC

hydrocortisone; systemic

2.3

13.9

422

C09CA01

ATC

losartan; oral

1.3

13.8

1033

8192

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

13.8

1180

9536

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

5.6

13.8

N05AH03

ATC

olanzapine; systemic

1.7

13.8

245

1459

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.7

13.7

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

13.7

128

618

A10BH01

ATC

sitagliptin; oral

1.5

13.7

386

2574

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

13.7

1129

9079

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

13.7

568

4096

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

13.7

277

1708

N05AF03

ATC

chlorprothixene; systemic

2.2

13.6

107

482

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

13.6

355

2327

N05AH02

ATC

clozapine; systemic

2.6

13.6

311

L40

ICD-10 Finland

Psoriasis

2.5

13.5

341

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

13.5

221

1285

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

13.5

203

1152

WX213

NOMESCO Finland

Lower leg blockade

3.6

13.5

124

A10BK03

ATC

empagliflozin; oral

1.5

13.5

392

2633

SPAT1097

SPAT

Recording of ECG

1.4

13.4

577

4186

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

13.4

262

1600

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.9

13.4

179

980

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

13.3

144

734

N06AX16

ATC

venlafaxine; oral

1.4

13.3

544

3912

L70.0

ICD-10 Finland

Acne vulgaris

2.4

13.3

393

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

13.2

1502

12580

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

13.2

3010

27316

S19

ICPC

Skin injury other

1.9

13.2

152

792

P16

ICPC

Acute alcohol abuse

2.6

13.1

275

N03AG01

ATC

valproic acid; systemic, rectal

1.7

13.1

229

1357

C02AC05

ATC

moxonidine; oral

1.8

13.0

184

1025

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

13.0

2359

20855

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

13.0

160

853

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

9.3

12.9

N06AB04

ATC

citalopram; systemic

1.4

12.9

809

6244

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

12.9

118

566

B01AA03

ATC

warfarin; systemic

1.4

12.8

743

5665

R03BA02

ATC

budesonide; inhalant

1.4

12.8

663

4963

L43.8

ICD-10 Finland

Other lichen planus

2.6

12.8

285

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.4

12.7

345

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.8

12.7

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

12.7

185

N18.0

ICD-10 Finland

End-stage renal disease

3.2

12.7

159

N06AB03

ATC

fluoxetine; oral

1.5

12.7

474

3349

127

Kela drug reimbursment

Transplant complication

2.7

12.7

240

Z72.0

ICD-10 Finland

Tobacco use

2.1

12.7

112

530

SPAT1285

SPAT

Provision of consultation response

1.7

12.6

212

1243

L71.8

ICD-10 Finland

Other rosacea

2.8

12.6

224

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.4

12.6

130

L30.2

ICD-10 Finland

Cutaneous autosensitization

32.1

12.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

12.5

2214

19486

X58

ICD-10 Finland

Exposure to other specified factors

1.4

12.5

555

4048

M48.0

ICD-10 Finland

Spinal stenosis

1.5

12.5

461

3251

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

12.4

349

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

12.4

501

3593

D07XB01

ATC

flumetasone; topical

3.7

12.3

103

SPAT1216

SPAT

Assessment of functional ability

1.4

12.3

579

4264

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

12.3

277

1753

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

12.3

635

4750

A07AA02

ATC

nystatin; oral

1.7

12.3

212

1252

SPAT1059

SPAT

Spirometry at the office

1.7

12.2

203

1186

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

12.2

358

H70

ICPC

Otitis externa

2.3

12.2

396

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

12.0

885

6988

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.6

12.0

253

SPAT1283

SPAT

Restricted health certificate

1.4

12.0

625

4683

A12AA04

ATC

calcium carbonate; oral

2.7

12.0

236

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

11.9

384

2634

S17

ICPC

Abrasion/scratch/blister

2.3

11.9

406

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

11.9

527

3841

B35.1

ICD-10 Finland

Tinea unguium

1.6

11.9

246

1526

R42

ICD-10 Finland

Dizziness and giddiness

1.3

11.8

863

6808

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.8

11.8

199

K28

ICPC

Limited function/disability (K)

2.2

11.7

409

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.2

11.7

409

R51.80

ICD-10 Finland

Headache

1.4

11.7

573

4250

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

11.7

125

636

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.7

505

3666

S06.0

ICD-10 Finland

Concussion

1.5

11.6

405

2822

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.6

11.6

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

65.1

11.6

D06BX01

ATC

metronidazole; topical

1.5

11.5

385

2660

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

3.7

11.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

11.5

143

765

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

11.5

400

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.9

11.5

180

JN4AD

NOMESCO Finland

Body CT examination

1.5

11.4

392

2723

A05

ICPC

Feeling ill

1.7

11.4

209

1255

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.7

11.4

225

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.2

11.4

414

L12

ICPC

Hand/finger symptom/complaint

1.4

11.4

613

4616

L03

ICPC

Low back symptom/complaint

1.3

11.4

1074

8765

ZXA10

NOMESCO Finland

Bilateral

1.3

11.3

704

5420

SCA02

NOMESCO Finland

Preventive oral health care

1.5

11.3

381

2636

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.3

1037

8429

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

11.3

794

6224

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

11.3

233

1444

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.3

11.3

340

QXA70

NOMESCO Finland

Guidance related to rash and skin care

35.1

11.3

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.1

11.2

101

483

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

5.5

11.2

L04AB01

ATC

etanercept; parenteral

2.6

11.1

251

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

11.1

311

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

11.1

175

1008

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.2

11.1

393

L93.0

ICD-10 Finland

Discoid lupus erythematosus

5.3

11.0

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

11.0

274

1776

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

11.0

205

1237

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

11.0

212

1291

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

11.0

266

1714

R06.2

ICD-10 Finland

Wheezing

1.8

11.0

169

967

T82

ICPC

Obesity

1.8

11.0

149

821

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

11.0

1066

8726

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

10.9

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

10.9

415

E000005, ,

ATC

43.4

10.9

S01GX08

ATC

ketotifen; ophthalmic

1.8

10.9

153

852

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

10.9

853

6788

C09AA05

ATC

ramipril; oral

1.3

10.9

983

7971

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

10.9

345

2360

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.9

894

7161

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

10.9

827

6555

N06AX12

ATC

bupropion; oral

1.6

10.8

249

1585

K70.1

ICD-10 Finland

Alcoholic hepatitis

3.9

10.8

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

3.9

10.8

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

10.8

130

689

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

10.8

443

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

10.8

346

2372

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

10.8

162

921

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

10.8

133

711

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

10.7

245

1557

C08CA13

ATC

lercanidipine; oral

1.4

10.7

531

3943

S84

ICPC

Impetigo

4.4

10.7

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

4.6

10.7

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.2

10.7

406

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.3

10.6

349

L25.8

ICD-10 Finland

Unspecified contact dermatitis due to other agents

60.1

10.6

N05BA04

ATC

oxazepam; oral

1.3

10.6

1011

8251

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

8.0

10.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

10.5

1928

16931

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.7

10.5

206

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

10.5

151

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.0

10.5

L56.4

ICD-10 Finland

Polymorphous light eruption

4.8

10.5

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.4

10.5

277

1653, ,

NOMESCO Finland

110.3

10.4

WXQ20

NOMESCO Finland

UVA broad spectrum light therapy

110.3

10.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

10.4

373

2614

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.2

10.4

391

RS340, ,

NOMESCO Finland

5.4

10.4

PD4AD

NOMESCO Finland

CT of lower extremity arteries

3.4

10.4

111

L16

ICPC

Ankle symptom/complaint

1.4

10.4

421

3020

A02BC05

ATC

esomeprazole; systemic

1.2

10.4

1639

14170

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

2.9

10.4

163

C08CA02

ATC

felodipine; oral

1.5

10.4

347

2400

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

10.3

345

2384

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

10.3

155

881

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.0

10.3

106

532

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

10.3

458

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

10.3

488

3596

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.3

974

7938

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

10.3

967

7874

RJ411, ,

NOMESCO Finland

3.9

10.3

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

10.3

215

1338

R03BA08

ATC

ciclesonide; inhalant

1.5

10.3

308

2082

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.0

10.3

153

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.9

10.3

119

623

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

10.3

213

1323

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

10.3

109

554

K90.0

ICD-10 Finland

Coeliac disease

2.0

10.3

109

554

K85

ICD-10 Finland

Acute pancreatitis

2.4

10.3

292

1200, ,

NOMESCO Finland

18.8

10.2

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

10.2

119

624

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.6

10.2

209

SFA20

NOMESCO Finland

Two-surface restoration

1.2

10.2

2475

22326

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

10.2

244

1569

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.2

845

6770

QBA10

NOMESCO Finland

Incision of skin of trunk

2.8

10.2

170

WX400

NOMESCO Finland

Inhalation anesthesy

1.8

10.2

161

930

N02BF02

ATC

pregabalin; oral

1.6

10.1

213

1327

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.1

10.1

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

10.1

376

A08

ICPC

Swelling

1.7

10.1

181

1082

PE1AT

NOMESCO Finland

Femoral artery PTA

2.7

10.1

188

K60.3

ICD-10 Finland

Anal fistula

2.3

10.1

307

L08

ICPC

Shoulder symptom/complaint

1.3

10.0

837

6710

L04AC05

ATC

ustekinumab; parenteral

4.3

10.0

L04AC10

ATC

secukinumab; parenteral

4.3

10.0

QXB99, ,

SPAT

2.2

10.0

391

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

10.0

378

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

10.0

667

5187

WQ066, ,

NOMESCO Finland

40.1

10.0

PHM76

NOMESCO Finland

Endovenous obliteration of v.saphena magna

1.8

9.9

139

774

R03AC12

ATC

salmeterol; inhalant

1.8

9.9

155

892

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.0

9.9

100

499

SPAT1324

SPAT

Screening procedure

1.3

9.9

617

4748

K50.8

ICD-10 Finland

Other Crohn disease

2.5

9.9

242

L43.0

ICD-10 Finland

Hypertrophic lichen planus

4.1

9.9

J01FA10

ATC

azithromycin; systemic

1.2

9.8

2380

21437

C10AA01

ATC

simvastatin; oral

1.2

9.8

1662

14453

T74.1

ICD-10 Finland

Physical abuse

2.3

9.8

292

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

4.4

9.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

9.8

393

2814

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

4.9

9.8

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.8

397

2849

D69.0

ICD-10 Finland

Allergic purpura

3.5

9.8

SAA04

NOMESCO Finland

Special examination of mouth

1.6

9.7

195

1201

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.8

9.7

169

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2.9

9.7

158

S22.3

ICD-10 Finland

Fracture of rib

1.5

9.7

277

1854

N02BF01

ATC

gabapentin; oral

1.5

9.7

305

2083

L15

ICPC

Knee symptom/complaint

1.3

9.7

891

7231

A10AB04

ATC

insulin lispro; parenteral

1.9

9.7

119

636

SPAT1247

SPAT

Outpatient detoxication and monitoring

4.1

9.7

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.4

9.7

263

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.1

9.7

423

A07EC02

ATC

mesalazine; oral, rectal

1.6

9.6

196

1212

TGC00

NOMESCO Finland

Bronchial lavation

2.1

9.6

457

C10AC01

ATC

colestyramine; oral

2.0

9.6

471

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

9.6

690

5420

A07EA06

ATC

budesonide; oral, local oral

1.8

9.6

130

717

P03

ICPC

Feeling depressed

1.5

9.5

338

2364

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.2

9.5

340

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

9.5

126

690

Z01.2

ICD-10 Finland

Dental examination

1.2

9.5

1831

16115

R55

ICD-10 Finland

Syncope and collapse

1.4

9.5

402

2906

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

9.5

117

627

SPAT1101

SPAT

Orthostatic test

1.8

9.4

150

868

SPAT1252

SPAT

Overall medication plan or its review

1.5

9.4

246

1616

WQ022, ,

NOMESCO Finland

+∞

9.4

P29

ICPC

Psychological sympt/compl other

1.6

9.4

240

1569

R06AX18

ATC

acrivastine; oral

2.0

9.3

476

TK800

NOMESCO Finland

Hemodialysis

2.1

9.3

402

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

9.3

348

2458

L40.4

ICD-10 Finland

Guttate psoriasis

4.4

9.3

B35.2

ICD-10 Finland

Tinea manuum

6.9

9.3

WX730

NOMESCO Finland

Conventional respirator

2.4

9.3

262

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.6

9.3

212

1350

I50.1

ICD-10 Finland

Left ventricular failure

1.6

9.2

184

1132

J01CF02

ATC

cloxacillin; systemic

2.1

9.2

417

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

9.2

916

7500

R03AC13

ATC

formoterol; inhalant

1.7

9.2

173

1048

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.2

328

2296

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.6

9.2

197

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

9.2

243

1599

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

3.5

9.2

-50

ICPC

Medication/prescr/renewal

1.7

9.2

151

882

A11CC03

ATC

alfacalcidol; systemic

2.0

9.2

445

E66.0

ICD-10 Finland

Obesity due to excess calories

2.7

9.2

169

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

9.2

301

N03AX09

ATC

lamotrigine; oral

1.7

9.1

166

997

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

9.1

201

1268

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

9.1

125

692

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

9.1

112

599

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

9.1

1137

9559

SFA00

NOMESCO Finland

Small restoration

1.4

9.1

524

3984

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

9.1

146

848

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.7

9.1

170

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

3.0

9.0

132

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.3

9.0

M10.0

ICD-10 Finland

Idiopathic gout

1.8

9.0

128

717

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.2

9.0

342

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.4

8.9

236

ZXH06, ,

SPAT

1.7

8.9

171

1042

Z37.0

ICD-10 Finland

Single live birth

0.5

8.9

1654

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.3

8.9

286

R03AC03

ATC

terbutaline; inhalant

1.4

8.9

494

3735

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

8.9

228

1492

ZYC01, ,

SPAT

1.4

8.9

341

2423

Z08

ICPC

Social welfare problem

2.5

8.9

213

Z94.0

ICD-10 Finland

Kidney transplant status

2.7

8.8

161

WX892

NOMESCO Finland

Monitored bed care

1.5

8.8

276

1883

Z3231

NOMESCO Finland

Registered nurse

1.2

8.8

1056

8832

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.1

8.8

118

A10BJ06

ATC

semaglutide; parenteral

1.6

8.8

186

1163

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

8.8

327

2310

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.5

8.8

220

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

8.7

215

1393

A10AD05

ATC

insulin aspart; parenteral

2.2

8.7

314

E66.8

ICD-10 Finland

Other obesity

1.6

8.7

191

1204

J01CR50

ATC

combinations of penicillins; systemic

7.2

8.7

R01AD09

ATC

mometasone; nasal

1.2

8.7

1796

15874

H29

ICPC

Ear symptom/complaint other

1.4

8.7

407

2993

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

8.7

180

1119

S01GX02

ATC

levocabastine; ophthalmic

1.6

8.7

195

1237

L40.2

ICD-10 Finland

Acrodermatitis continua

50.1

8.7

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

8.7

227

1492

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

8.7

598

4669

SPAT1284

SPAT

Extensive health certificate

1.9

8.6

102

539

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

8.6

652

5153

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.5

8.6

198

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

8.6

677

5379

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.7

8.6

B35.8

ICD-10 Finland

Other dermatophytoses

4.8

8.6

B08.1

ICD-10 Finland

Molluscum contagiosum

4.8

8.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

8.6

114

626

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

8.6

250

1682

R18

ICD-10 Finland

Ascites

2.1

8.5

356

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

3.6

8.5

SPAT1193

SPAT

Pap smear

1.5

8.5

304

2129

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.5

296

2063

L28

ICPC

Limited function/disability (L)

1.3

8.5

636

5019

J01CA04

ATC

amoxicillin; systemic

1.2

8.5

3653

34489

SGA01

NOMESCO Finland

Emergency treatment

1.3

8.5

617

4850

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

8.5

463

3491

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

8.5

684

5453

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

27.5

8.5

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

8.5

100

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

20.0

8.5

W19

ICD-10 Finland

Unspecified fall

1.4

8.5

353

2546

XQ806

NOMESCO Finland

Minimal Erythema Dose (MED) test

90.2

8.4

SPAT1139

SPAT

Nutrition survey

1.8

8.4

117

652

H3603, E103,

ICD-10 Finland

2.8

8.4

149

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.5

8.4

207

L04AB06

ATC

golimumab; parenteral

3.1

8.4

106

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

8.3

667

5311

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

8.3

138

809

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

8.3

105

567

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

8.3

E86

ICD-10 Finland

Volume depletion

2.0

8.3

462

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

8.3

105

568

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

8.3

241

1621

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

8.3

641

5082

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.6

8.3

167

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.6

8.2

177

1111

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

8.2

128

737

AN1

Coronary angiography

1.4

8.2

409

3038

R01AD12

ATC

fluticasone furoate; nasal

1.2

8.2

1188

10130

R52.2

ICD-10 Finland

Other chronic pain

1.7

8.2

133

775

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

8.2

185

1175

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

8.2

189

1207

C84.0

ICD-10 Finland

Mycosis fungoides

14.5

8.2

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

8.2

1014

8506

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

8.2

514

S91.0

ICD-10 Finland

Open wound of ankle

2.7

8.2

151

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.7

8.2

151

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.7

8.1

157

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

8.1

237

1595

Z72.1

ICD-10 Finland

Alcohol use

2.4

8.1

210

N05AD01

ATC

haloperidol; systemic

1.8

8.1

113

630

K92.0

ICD-10 Finland

Haematemesis

1.9

8.1

473

L03.8

ICD-10 Finland

Cellulitis of other sites

3.6

8.1

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.8

8.1

146

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

8.1

959

8004

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.5

8.1

216

1427

B01AB10

ATC

tinzaparin; parenteral

1.4

8.1

372

2729

SPA47

NOMESCO Finland

Precision impression for denture

1.9

8.1

495

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.4

8.0

211

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.9

8.0

130

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

8.0

280

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

8.0

139

826

J05AB01

ATC

aciclovir; systemic

1.3

8.0

795

6502

D82

ICPC

Teeth/gum disease

1.2

8.0

1444

12583

S94

ICPC

Ingrowing nail

2.2

8.0

287

E87.6

ICD-10 Finland

Hypokalaemia

1.8

8.0

116

656

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

7.9

543

4232

SPAT1104

SPAT

Monitoring of emergency patient

1.5

7.9

238

1612

S10

ICPC

Boil/carbuncle

1.5

7.9

208

1369

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

3.3

7.9

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

7.9

408

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.1

7.9

354

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

7.9

133

784

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

7.9

302

2145

SPAT1053

SPAT

Memory test

1.3

7.9

500

3856

V03AE01

ATC

polystyrene sulfonate; oral

2.5

7.9

195

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

7.9

207

1363

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

4.6

7.9

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

7.8

400

2984

R04.0

ICD-10 Finland

Epistaxis

1.5

7.8

271

1888

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

7.8

113

637

B82

ICPC

Anaemia other/unspecified

1.9

7.8

101

550

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

7.8

458

HMAK, ,

NOMESCO Finland

1.4

7.8

425

3203

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.8

855

7071

UKC02

NOMESCO Finland

Cystoscopy

1.3

7.8

611

4852

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.6

7.8

185

1191

M70.2

ICD-10 Finland

Olecranon bursitis

1.7

7.8

125

728

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.0

7.8

111

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

7.7

208

1376

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.2

7.7

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.7

298

2120

L29

ICD-10 Finland

Pruritus

2.5

7.7

185

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

7.7

311

L09

ICPC

Arm symptom/complaint

1.6

7.7

166

1044

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

7.7

253

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

7.7

217

1451

A10AD04

ATC

insulin lispro; parenteral

3.9

7.7

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.7

7.7

139

J01FA09

ATC

clarithromycin; systemic

1.2

7.7

1206

10360

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

4.3

7.7

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.6

7.7

162

Z2446

NOMESCO Finland

Social worker

1.5

7.7

222

1493

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.0

7.7

372

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.7

7.7

127

746

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

3.2

7.6

SBA00

NOMESCO Finland

Microbiological examinations

1.9

7.6

476

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

7.6

531

4148

D11

ICPC

Diarrhoea

1.4

7.6

411

3094

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

7.6

174

1110

Z49.2

ICD-10 Finland

Other dialysis

3.0

7.6

107

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

7.6

186

1206

K04.0

ICD-10 Finland

Pulpitis

1.4

7.6

331

2407

A10BB12

ATC

glimepiride; oral

1.5

7.6

240

1644

R01AD11

ATC

triamcinolone; nasal

1.4

7.6

299

2136

L98.1

ICD-10 Finland

Factitial dermatitis

11.8

7.6

SPD01

NOMESCO Finland

Mucosa-supported complete denture

2.7

7.6

146

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.5

7.6

181

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

7.5

150

925

L04AD02

ATC

tacrolimus; systemic

2.6

7.5

152

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

10.0

7.5

NHG20

NOMESCO Finland

Fusion of talocrural joint

3.2

7.5

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

7.5

213

1427

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

7.5

220

1484

Z00.0

ICD-10 Finland

General medical examination

1.3

7.5

718

5846

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.5

7.5

182

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.5

228

1551

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

7.5

516

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

7.4

360

2663

J45.8

ICD-10 Finland

Mixed asthma

1.8

7.4

105

589

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.6

7.4

159

R68.8

ICD-10 Finland

Other specified general symptoms and signs

3.1

7.4

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

7.4

166

1054

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

7.4

250

1735

R52.9

ICD-10 Finland

Pain, unspecified

1.4

7.4

336

2460

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.5

7.4

183

R05

ICD-10 Finland

Cough

1.3

7.4

789

6504

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

7.4

156

977

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

7.4

106

598

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

7.3

338

2480

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

7.3

183

1192

L91.0

ICD-10 Finland

Hypertrophic scar

2.4

7.3

202

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

7.3

468

3613

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

7.3

134

809

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

7.3

209

1402

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

7.3

782

6448

-34

ICPC

Blood test

1.8

7.3

108

615

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

7.3

211

1421

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

7.2

163

1038

A28

ICPC

Limited function/disability NOS

1.3

7.2

587

4684

N06AB10

ATC

escitalopram; oral

1.3

7.2

744

6110

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

7.2

205

1375

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.6

7.2

150

M03BX02

ATC

tizanidine; oral

1.2

7.2

2594

23929

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

7.2

406

3079

I50

ICD-10 Finland

Heart failure

1.8

7.2

100

559

H3601, E103,

ICD-10 Finland

2.7

7.2

133

A10AE06

ATC

insulin degludec; parenteral

1.7

7.2

123

730

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.7

7.2

117

685

N05AX12

ATC

aripiprazole; systemic

1.7

7.2

129

776

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

7.1

184

1207

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

30.0

7.1

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.7

7.1

139

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.3

7.1

217

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

7.1

352

2613

SDA03

NOMESCO Finland

Periodontal treatment

1.2

7.1

1577

13967

R06.5

ICD-10 Finland

Mouth breathing

1.4

7.1

333

2451

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.4

7.1

205

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

3.4

7.1

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

7.1

224

1534

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

3.2

7.1

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

2.6

7.1

151

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

7.1

1608

14270

L24

ICD-10 Finland

Irritant contact dermatitis

7.9

7.1

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

7.1

440

3383

WX419

NOMESCO Finland

Other general anesthesy

2.7

7.1

134

Q82.88

ICD-10 Finland

Other specified congenital malformations of skin

12.0

7.1

N05BA02

ATC

chlordiazepoxide; systemic

1.9

7.1

475

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

7.1

218

1487

N05AF05

ATC

zuclopenthixol; systemic

2.7

7.0

140

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

7.0

1361

11909

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

4.2

7.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.5

7.0

184

1213

R21

ICPC

Throat symptom/complaint

1.3

7.0

730

6000

H60.3

ICD-10 Finland

Other infective otitis externa

1.9

7.0

441

QXA70, ,

SPAT

2.4

7.0

182

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

7.0

139

858

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

7.0

222

1523

N03AE01

ATC

clonazepam; systemic

1.5

7.0

198

1327

Z2221

NOMESCO Finland

Medical doctor

0.8

7.0

735

8852

ZXA05

NOMESCO Finland

Left side

1.2

7.0

913

7693

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

7.0

435

3348

S82.3

ICD-10 Finland

Fracture of lower end of tibia

1.9

6.9

393

A02BA02

ATC

ranitidine; systemic

1.3

6.9

698

5713

A12BA01

ATC

potassium chloride; oral

1.6

6.9

142

883

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.6

6.9

173

1128

G56.8

ICD-10 Finland

Other mononeuropathies of upper limb

3.7

6.9

A10BJ02

ATC

liraglutide; parenteral

1.8

6.9

100

566

C07AB02

ATC

metoprolol; systemic

1.2

6.8

729

6008

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

4.1

6.8

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

3.8

6.8

R03DA04

ATC

theophylline; systemic, rectal

1.6

6.8

166

1077

120

Kela drug reimbursment

Hypogammaglobulinaemia

9.3

6.8

C10AA05

ATC

atorvastatin; oral

1.2

6.8

1652

14741

L44.0

ICD-10 Finland

Pityriasis rubra pilaris

40.1

6.8

H61.0

ICD-10 Finland

Perichondritis of external ear

4.3

6.7

SPAT1325

SPAT

Vaccination

1.2

6.7

1267

11052

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

6.7

106

615

L60.0

ICD-10 Finland

Ingrowing nail

1.6

6.7

159

1024

SPAT1210

SPAT

Application of cast or individual aid

1.6

6.7

139

867

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.5

6.7

1437

137

Kela drug reimbursment

Uraemia requiring dialysis

2.7

6.7

121

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.7

6.7

111

654

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

2.8

6.7

110

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

6.6

4141

39857

S86

ICPC

Dermatitis seborrhoeic

3.7

6.6

A10AD01

ATC

insulin (human); parenteral

2.0

6.6

310

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

6.6

270

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.5

6.6

166

1084

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1.9

6.6

393

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

3.0

6.6

N05CF02

ATC

zolpidem; oral

1.3

6.6

632

5142

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.9

6.6

450

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

6.6

198

1344

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3.1

6.6

PHT99

NOMESCO Finland

Injection of therapeutic or sclerosing agent into other vein

2.8

6.6

111

H04AA01

ATC

glucagon; nasal, parenteral

1.9

6.6

401

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.6

6.6

143

904

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.7

6.5

117

703

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

3.3

6.5

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

4.2

6.5

J43.9

ICD-10 Finland

Emphysema, unspecified

2.1

6.5

265

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

10.0

6.5

IHZ01, ,

SPAT

3.0

6.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

6.5

416

N04AA02

ATC

biperiden; systemic

2.0

6.5

353

WZC30, ,

SPAT

1.5

6.5

194

1315

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.5

6.5

164

A41.8

ICD-10 Finland

Other specified sepsis

2.0

6.5

326

B80

ICPC

Iron deficiency anaemia

1.8

6.5

474

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.5

373

2836

49300

ICD-8 Finland

Asthma, bronchiale

1.9

6.5

417

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

1.9

6.5

403

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

2.6

6.5

129

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

6.5

147

939

L50.1

ICD-10 Finland

Idiopathic urticaria

3.1

6.5

L04AK01

ATC

leflunomide; oral

3.1

6.5

SPAT1234

SPAT

Support of social functional capacity

1.5

6.4

169

1115

K77

ICPC

Heart failure

2.0

6.4

355

SPAT1172

SPAT

Guidance concerning hydration

1.9

6.4

376

S01GX06

ATC

emedastine; ophthalmic

2.5

6.4

153

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

6.4

440

N17.8

ICD-10 Finland

Other acute renal failure

2.2

6.4

215

OAB74, ,

SPAT

2.8

6.4

107

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

6.4

520

QDG00

NOMESCO Finland

Debridement of bedsore of lower limb

7.4

6.4

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

6.4

226

1584

WVA20

NOMESCO Finland

Medicine administration

1.8

6.4

491

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

6.4

126

777

S70.0

ICD-10 Finland

Contusion of hip

1.6

6.4

133

832

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.9

6.4

363

N06

ICPC

Sensation disturbance other

2.4

6.4

178

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

6.4

155

1006

NG4AD

NOMESCO Finland

Lower leg CT

3.7

6.4

PHD78

NOMESCO Finland

Resection of communicating veins of lower leg and thigh

2.9

6.4

102

B05DA

ATC

Isotonic solutions

2.9

6.4

102

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.4

6.3

222

1553

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.5

6.3

142

F29

ICPC

Eye symptom/complaint other

1.4

6.3

324

2420

L01

ICPC

Neck symptom/complaint

1.3

6.3

541

4341

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.0

6.3

WX402

NOMESCO Finland

General anaesthesia

1.2

6.3

793

6646

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

6.3

242

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

5.2

6.3

P76

ICPC

Depressive disorder

1.5

6.3

207

1431

L18

ICPC

Muscle pain

1.6

6.3

138

874

A10BH05

ATC

linagliptin; oral

1.5

6.3

170

1129

L41.1

ICD-10 Finland

Pityriasis lichenoides chronica

11.0

6.3

P06

ICPC

Sleep disturbance

1.3

6.3

407

3149

J96.1

ICD-10 Finland

Chronic respiratory failure

1.9

6.3

393

K86.3

ICD-10 Finland

Pseudocyst of pancreas

3.5

6.3

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.6

6.3

145

930

PD4DG

NOMESCO Finland

Very extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.3

6.3

WVA20, ,

SPAT

1.8

6.3

531

A10AB01

ATC

insulin (human); parenteral

1.6

6.3

121

743

-69

ICPC

Other reason for encounter NEC

1.6

6.3

129

805

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

3.8

6.3

69109

ICD-8 Finland

Infantile eczema and related conditions, Unspecified

+∞

6.2

69009

ICD-8 Finland

Seborrhoeic dermatitis, Unspecified

+∞

6.2

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.2

6.2

211

A01AB09

ATC

miconazole; local oral

1.4

6.2

284

2083

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.2

6.2

218

L04AC18

ATC

risankizumab; parenteral

7.0

6.2

OAB95, ,

SPAT

0.6

6.2

112

1803

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

6.2

156

1020

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.2

578

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.2

381

2928

U02

ICPC

Urinary frequency/urgency

1.3

6.1

473

3746

K92

ICPC

Atherosclerosis/periph vascular dis

2.2

6.1

219

ZXE40

NOMESCO Finland

More than seven and less than nine hours

1.8

6.1

461

L95.8

ICD-10 Finland

Other vasculitis limited to skin

5.7

6.1

OAB47, ,

SPAT

1.6

6.1

131

825

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.6

6.1

127

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

6.1

105

625

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

6.1

110

663

IHZ05, ,

SPAT

1.7

6.1

108

648

H03AA01

ATC

levothyroxine sodium; systemic

1.2

6.1

829

7004

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

6.1

139

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

6.1

326

2453

HAHOM, ,

NOMESCO Finland

2.3

6.1

188

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

1.7

6.1

107

641

VALMI, ,

NOMESCO Finland

1.2

6.1

905

7715

XQ820

NOMESCO Finland

Exposure to medicinal substance

4.1

6.1

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.1

347

2637

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.0

6.1

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

6.1

364

2787

-44

ICPC

Preventive immunization/medic

1.4

6.1

282

2076

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.6

6.0

121

750

SPAT1131

SPAT

Colonoscopy

1.7

6.0

106

635

L88

ICD-10 Finland

Pyoderma gangrenosum

6.7

6.0

ZXC50

NOMESCO Finland

Cryotherapy

1.7

6.0

575

L78

ICPC

Sprain/strain of knee

2.2

6.0

221

N05AA01

ATC

chlorpromazine; systemic, rectal

2.2

6.0

221

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

6.0

435

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

187

20.19

242.84

1.5

25.23

21.19

u/ml

0.30

(40768443) Skin Pathology biopsy report

537

1225

4.79

219.74

1.4

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

155

20.47

202.86

1.2

1.4

48.00

46.67

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

158

19.39

201.80

1.2

1.4

276.67

80.00

titre

—

(3007853) Bacteria identified in Skin by Aerobe culture

1035

4369

2.72

160.57

2.2

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

636

2051

3.41

158.85

1.4

1.3

792.41

150.10

u/ml

7.71

599

1885

(40760892) CBC W Ordered Manual Differential panel - Blood

2710

18500

2.01

124.26

8.7

6.1

—

(3000494) Fungus identified in Specimen by Culture

912

4357

2.34

104.56

1.7

1.4

—

(3001604) Monocytes [#/volume] in Blood

2753

19690

1.88

101.48

7.8

5.6

0.63

0.59

e9/l

13.12

2553

16948

(3006315) Basophils [#/volume] in Blood

2757

19735

1.88

101.29

7.8

5.6

0.05

0.04

e9/l

11.62

2557

16985

(3013115) Eosinophils [#/volume] in Blood

2822

20427

1.87

99.26

8.1

5.8

0.23

0.19

e9/l

23.57

2626

17865

(3019198) Lymphocytes [#/volume] in Blood

2789

20297

1.84

94.47

8.0

5.7

1.92

1.93

e9/l

0.08

2613

17894

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1899

12370

1.86

91.19

3.0

2.5

58.59

65.86

u/l

0.54

1762

11431

(3013650) Neutrophils [#/volume] in Blood by Automated count

2993

22904

1.76

79.20

10.7

8.9

4.35

4.10

e9/l

6.94

2794

19906

(3022217) INR in Platelet poor plasma by Coagulation assay

2505

18559

1.70

71.46

17.6

15.0

1.24

1.27

inr

1.22

925

5447

(3024561) Albumin [Mass/volume] in Serum or Plasma

2333

16986

1.70

70.81

5.9

4.8

34.76

35.55

g/l

8.63

2175

15804

(3023368) Bacteria identified in Blood by Culture

1618

10674

1.76

70.10

5.3

4.2

—

(3019069) Monocytes/100 leukocytes in Blood

2505

18682

1.68

68.66

8.4

6.1

8.81

8.61

2.33

2405

17489

(3006504) Eosinophils/100 leukocytes in Blood

2490

18573

1.68

67.95

8.0

5.8

3.25

2.81

13.29

2388

17343

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2709

20689

1.67

67.21

6.2

11.30

11.65

umol/l

0.51

2569

19653

(3029937) Albumin [Presence] in Urine by Test strip

1585

10604

1.72

64.11

5.2

3.8

0.00

estimate

0.19

619

3560

(3022096) Basophils/100 leukocytes in Blood

2410

18002

1.65

63.97

8.1

5.9

0.69

0.67

1.28

2315

16776

(3002030) Lymphocytes/100 leukocytes in Blood

2534

19231

1.64

62.67

8.2

5.9

26.55

27.85

7.70

2434

18033

(3042936) Bacteria identified in Isolate by Culture

949

5511

1.89

61.42

2.5

2.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3565

29596

1.71

61.29

5.3

3.8

14.34

11.82

mm/h

16.23

3300

27405

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3684

30869

1.73

61.08

9.0

7.4

80.32

77.92

u/l

1.58

3527

29133

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2089

15187

1.64

60.70

5.0

3.6

—

(3019060) Gas panel - Arterial blood

536

2575

2.21

58.45

5.4

4.6

—

(3018010) Neutrophils/100 leukocytes in Blood

2479

18935

1.61

57.98

7.9

5.8

57.73

57.31

0.99

2376

17736

(3017181) Myelocytes/100 leukocytes in Blood

636

3321

2.05

55.70

4.7

4.0

0.77

0.92

1.12

217

1115

(3002179) Metamyelocytes/100 leukocytes in Blood

586

3027

2.06

52.70

4.5

3.8

0.59

0.72

1.02

192

972

(3013826) Glucose [Moles/volume] in Serum or Plasma

2931

23618

1.58

52.22

6.0

4.5

6.82

6.73

mmol/l

1.45

2771

22094

(3037522) Nuclear Ab [Titer] in Serum

856

5048

1.84

51.92

1.4

1.3

452.02

540.63

titre

0.90

173

991

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1261

8359

1.68

50.55

1.4

1.2

1.51

1.87

u/ml

0.71

389

2209

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2510

19614

1.56

50.46

8.3

6.6

1.21

mmol/l

3.89

2045

16695

(3021440) Promyelocytes/100 leukocytes in Blood

595

3156

2.00

49.57

4.8

4.1

0.08

0.12

0.69

177

950

(3025159) Blasts/100 leukocytes in Blood

572

3006

2.02

48.88

4.8

4.1

0.66

0.15

0.44

156

810

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

7.46

48.71

1.6

1.5

9.92

8.27

ug/l

1.54

(3008152) Bicarbonate [Moles/volume] in Arterial blood

492

2464

2.11

47.87

8.1

6.7

24.65

24.52

mmol/l

0.32

464

2345

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1991

14955

1.55

46.55

4.5

3.5

35.99

85.20

ng/l

0.92

1416

10138

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1663

11998

1.58

46.47

2.4

2.1

225.60

228.48

u/l

0.03

1544

11266

(3021601) Nitrite [Presence] in Urine by Test strip

2477

19559

1.53

45.69

6.0

4.7

0.00

estimate

0.28

642

3701

(3035350) Ketones [Presence] in Urine by Test strip

2482

19619

1.52

45.47

4.8

3.5

0.01

0.00

estimate

0.32

660

3916

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

709

4098

1.85

45.39

4.6

3.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2500

19803

1.52

45.27

4.8

3.5

0.00

estimate

1.32

598

3587

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1416

9915

1.60

44.59

2.6

2.2

3.07

2.89

mg/l

1.75

1239

8488

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1234

8426

1.62

42.86

1.8

1.7

18416278.90

35281129.60

pmol/l

0.74

1010

7018

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3563

30758

1.55

40.82

4.4

3.8

14.85

14.76

pmol/l

1.32

3248

28034

(40761536) Microorganisms panel - Urine sediment

603

3433

1.86

40.21

4.8

3.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

378

1837

2.14

39.56

4.3

3.4

25.19

25.25

mmol/l

0.12

371

1772

(3037467) Urinalysis macro (dipstick) panel - Urine

3262

27726

1.50

39.38

5.2

4.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

963

6347

1.64

37.99

2.0

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

569

3256

1.84

37.18

4.7

3.7

1.23

mmol/l

0.32

498

2855

(3003396) Base excess in Arterial blood by calculation

735

4548

1.72

36.75

7.4

7.1

1.33

1.05

mmol/l

1.16

564

3582

(3016502) Oxygen saturation in Arterial blood

676

4086

1.76

36.74

7.6

7.5

95.83

95.60

0.59

639

3933

(3003458) Phosphate [Moles/volume] in Serum or Plasma

807

5123

1.69

36.70

7.2

5.8

1.06

1.03

mmol/l

1.32

752

4767

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2226

17768

1.45

35.47

7.3

5.8

1.20

1.21

mmol/l

2.88

2028

16230

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

732

4566

1.71

35.45

7.4

7.1

5.12

5.09

kpa

0.31

690

4361

(3027801) Oxygen [Partial pressure] in Arterial blood

731

4565

1.70

35.23

7.4

7.1

11.26

12.45

kpa

11.60

687

4357

(3002173) Hemoglobin [Mass/volume] in Arterial blood

628

3760

1.77

35.19

7.8

7.9

121.48

122.08

g/l

0.28

607

3659

(3018418) pH of Serum or Plasma

1552

11559

1.50

35.18

4.6

4.0

7.40

0.37

398

2239

(3020891) Body temperature

315

1497

2.18

34.83

6.0

4.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

963

6473

1.60

34.71

3.7

3.3

0.80

0.82

mmol/l

4.91

903

6081

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

164

575

2.91

34.63

1.2

1.3

—

(3015736) pH of Urine

1999

15701

1.45

34.32

4.4

3.2

5.72

5.85

0.76

1201

(3015171) Extractable nuclear Ab [Units/volume] in Serum

292

1361

2.22

33.87

1.3

1.2

0.19

0.80

u/ml

2.46

122

(3019309) Folate [Moles/volume] in Red Blood Cells

1031

7134

1.56

32.55

2.0

1.7

1250.95

1163.02

nmol/l

2.24

782

5398

(3026008) Bacteria identified in Urine by Culture

1561

11784

1.47

32.50

3.6

3.0

—

(3012544) pH of Venous blood

616

3754

1.73

32.27

5.1

3.7

7.39

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1474

11020

1.48

32.17

3.5

3.0

1856.49

1427.50

ng/l

1.72

1262

9426

(3041096) Erythrocytes [Presence] in Urine by Automated

1441

10728

1.48

32.12

4.4

3.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

316

1552

2.11

32.07

1.4

1.5

3.00

17.74

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1052

7354

1.54

31.61

1.5

2.76

2.46

g/l

3.85

688

4523

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

480

2737

1.83

31.52

1.9

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

432

2385

1.89

31.41

4.6

3.2

125.14

129.66

g/l

3.85

424

2318

(3036481) Cortisol [Moles/volume] in Serum or Plasma

581

3517

1.74

31.12

2.4

2.1

364.98

375.92

nmol/l

0.57

537

3220

(3020682) Albumin/Creatinine [Ratio] in Urine

1615

12396

1.45

30.35

4.3

3.8

13.75

8.83

mg/mmol

2.89

1080

7950

(3021447) Carbon dioxide [Partial pressure] in Venous blood

589

3608

1.72

30.18

5.1

3.8

5.89

5.83

kpa

0.70

574

3493

(3021589) Normoblasts [#/volume] in Blood

2186

17739

1.41

30.04

13.5

9.2

0.00

e9/l

0.43

1942

14459

(3022948) Iron [Moles/volume] in Serum or Plasma

908

6208

1.56

29.95

3.0

2.4

12.38

13.21

umol/l

2.69

845

5808

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

678

4331

1.65

29.63

1.9

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

525

3144

1.75

29.13

2.2

2.7

66.75

66.38

g/l

0.49

483

2856

(3043409) Potassium [Moles/volume] in Arterial blood

245

1133

2.22

28.95

5.2

4.1

3.87

3.90

mmol/l

0.47

240

1123

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1707

13335

1.42

28.75

3.8

3.2

36.13

35.64

u/l

0.06

1590

12680

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

112

351

3.24

28.72

1.7

1.4

25.28

32.90

1.35

208

(3002032) Base excess in Venous blood by calculation

581

3602

1.69

28.40

5.1

3.8

2.07

2.01

mmol/l

0.13

489

3018

(3019150) Specific gravity of Urine by Refractometry

1174

8565

1.48

28.35

5.3

3.8

1.02

kg/l

1.67

189

1321

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

671

4325

1.64

28.21

1.9

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

277

1360

2.10

28.11

5.0

3.8

1.41

1.38

mmol/l

0.16

271

1339

(3004789) Transferrin [Mass/volume] in Serum or Plasma

840

5736

1.56

27.64

3.0

2.4

2.33

2.32

g/l

0.08

772

5325

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

689

4494

1.62

27.57

3.9

4.2

239.10

243.28

u/l

0.35

657

4252

(3024354) Oxygen [Partial pressure] in Venous blood

491

2939

1.74

27.22

4.7

3.1

4.48

4.62

kpa

0.94

474

2837

(3012516) Albumin [Mass/volume] in Urine

1527

11788

1.42

27.11

3.6

3.2

580.53

308.00

mg/l

1.21

1030

7611

(3026493) Urate [Moles/volume] in Serum or Plasma

1389

10545

1.44

27.03

3.0

2.6

3744.89

4638.41

umol/l

0.36

1222

9265

(3023520) Reticulocytes [#/volume] in Blood

528

3233

1.71

26.96

2.4

71.66

68.89

e9/l

1.04

427

2445

(3009508) Creatinine [Moles/volume] in Urine

1619

12640

1.41

26.93

3.6

3.2

7.51

7.74

mmol/l

1.17

1352

10678

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

241

1140

2.17

26.93

2.2

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

224

1029

2.23

26.91

1.6

1.14

1.18

g/l

1.01

213

969

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

318

1672

1.96

26.69

5.7

4.9

1.78

1.63

296

1563

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

577

3635

1.66

26.44

2.4

2.2

0.20

0.21

g/l

1.49

530

3388

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

299

1556

1.98

25.85

2.0

1.9

1.48

2.85

ug/l

1.46

271

1378

(3007930) Methemoglobin/Hemoglobin.total in Blood

312

1650

1.95

25.74

5.8

5.0

0.91

0.89

0.43

291

1547

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1173

8698

1.45

25.66

2.0

1.7

1.20

1.23

mg/l

0.13

921

6652

(1616796) Gas panel - Central venous blood

200

895

2.29

25.59

4.7

3.5

—

(3047181) Lactate [Moles/volume] in Blood

262

1305

2.06

25.58

6.1

5.7

1.24

1.29

mmol/l

0.49

230

1148

(3020779) Urea [Moles/volume] in Serum or Plasma

556

3500

1.66

25.52

9.8

7.4

10.76

9.97

mmol/l

1.61

532

3323

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

214

992

2.21

25.15

1.6

0.23

0.24

g/l

0.37

199

938

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

324

1749

1.91

25.14

3.9

2.6

0.69

0.64

2.29

324

1737

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

783

5368

1.54

25.10

3.1

2.5

21.43

23.17

2.47

628

4585

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

240

1165

2.11

25.10

1.7

1.5

5.36

7.80

iu/ml

0.14

256

(3031040) Bacteria [#/volume] in Urine by Automated count

3029

26396

1.37

25.01

5.1

4.2

133.36

1394.14

e6/l

3.44

371

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

329

1792

1.89

24.84

3.9

2.6

1.38

1.23

1.87

329

1781

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4056

37186

1.47

24.72

5.2

4.5

1.91

2.16

mu/l

1.64

3740

34151

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

223

1067

2.14

24.21

2.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

431

2569

1.74

24.17

1.8

2.4

—

(40767503) Oxygen content in Capillary blood by calculation

189

850

2.27

23.91

3.2

2.4

16.43

16.19

0.34

109

420

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4381

40881

1.56

23.85

20.7

13.5

23.72

24.10

mg/l

0.32

3781

32221

(40761535) Cells panel - Urine sediment

503

3148

1.66

23.53

4.2

3.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

124

462

2.73

23.46

1.6

1.5

58.92

56.73

0.21

286

(3014576) Chloride [Moles/volume] in Serum or Plasma

725

4967

1.54

23.17

8.0

6.8

103.79

104.53

mmol/l

3.43

725

4962

(3021960) Folate [Moles/volume] in Serum or Plasma

1195

9043

1.42

23.02

1.6

1.5

18.83

20.41

nmol/l

3.56

1050

7732

(3027231) Wheat IgE Ab [Units/volume] in Serum

8.57

22.76

1.0

0.65

0.29

u/ml

1.05

(3027945) Reticulocytes/100 erythrocytes in Blood

648

4358

1.56

22.47

2.3

2.5

1.89

1.76

1.74

570

3852

(3012494) Peanut IgE Ab [Units/volume] in Serum

5.73

22.39

1.1

3.27

3.32

u/ml

0.00

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

904

6527

1.47

22.33

1.3

28.66

31.74

iu/ml

0.38

319

2083

(3019550) Sodium [Moles/volume] in Serum or Plasma

4460

41920

1.57

22.01

22.6

15.5

139.30

139.69

mmol/l

19.81

4377

40904

(40760888) Immunoglobulin light chains.free panel - Serum

189

891

2.17

21.33

1.8

3.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

239

1235

1.98

21.08

1.5

1.6

983.13

357.41

titre

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4466

42060

1.56

21.04

22.7

15.7

3.98

3.97

mmol/l

1.41

4379

40963

(3000850) Epithelial cells [#/volume] in Urine

1104

8397

1.40

20.28

3.1

2.6

5.18

5.37

e6/l

0.19

1010

7536

(3039000) Anion gap in Blood

190

919

2.11

20.09

7.1

6.6

11.24

11.20

mmol/l

0.05

170

824

(3018572) Chloride [Moles/volume] in Blood

190

920

2.11

20.03

7.1

6.6

104.56

105.32

mmol/l

1.36

170

825

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1928

16028

1.33

19.96

2.7

2.2

74.40

76.91

nmol/l

3.53

1769

14458

(3015377) Calcium [Moles/volume] in Serum or Plasma

1626

13197

1.34

19.79

3.2

3.4

2.35

mmol/l

0.73

1445

11638

(3048689) Calprotectin [Mass/mass] in Stool

665

4631

1.50

19.45

2.9

2.3

159.04

133.45

ug/g

0.88

533

3666

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2043

17173

1.32

19.39

3.4

2.8

141.90

131.08

ug/l

0.72

1894

15929

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

849

6209

1.44

19.33

1.3

1.2

8.55

12.43

u/ml

1.21

357

2422

(3012501) Base excess in Blood by calculation

188

920

2.08

19.29

5.8

4.0

3.05

2.54

mmol/l

1.26

137

611

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

240

1282

1.92

19.22

2.6

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

697

4922

1.48

19.01

2.0

1.7

1.70

1.46

7.42

590

4338

(3023183) Ammonium ion [Moles/volume] in Plasma

173

834

2.11

18.47

2.9

3.0

31.74

35.87

umol/l

1.53

155

753

(3005719) IgG [Mass/volume] in Serum or Plasma

451

2921

1.60

18.25

3.1

2.6

10.94

10.61

g/l

0.76

416

2651

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

364

2236

1.68

18.19

1.7

1.5

—

(3021901) Oxygen saturation in Capillary blood

155

726

2.17

17.83

2.9

3.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

110

4.21

17.61

4.1

3.0

7.53

8.19

mg/l

0.29

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

198

1021

1.98

17.61

1.5

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

242

1337

1.85

17.48

2.6

2.3

531.40

700.33

ug/l

0.35

231

1263

(3026782) Osmolality of Urine

1038

8003

1.37

17.19

3.7

2.8

522.09

548.02

mosm/kgh2o

3.40

915

6884

(3026389) Candida sp identified in Specimen by Organism specific culture

122

525

2.36

17.18

1.4

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3038

27205

1.30

16.98

4.0

3.0

58.00

48.01

u/l

5.81

2828

25370

(3010421) pH of Blood

204

1078

1.93

16.90

5.7

4.0

7.42

0.24

194

982

(3034891) Synovial lining cells/100 cells in Synovial fluid

179

3.38

16.79

1.5

1.4

3.13

3.05

0.02

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

386

2461

1.62

16.65

8.9

9.1

0.69

0.67

0.46

379

2444

(3020961) Endomysium IgA Ab [Titer] in Serum

294

1746

1.73

16.64

1.2

1.1

77.50

134.56

titre

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

157

760

2.10

16.62

5.1

5.6

431.19

2636.81

iu/ml

0.58

113

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

386

2470

1.61

16.40

8.8

8.9

1.51

1.34

2.96

377

2455

(3009343) pH of Capillary blood

388

2495

1.60

16.15

3.6

3.7

7.41

0.41

292

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

392

2529

1.60

16.09

3.6

3.7

5.17

5.15

kpa

0.22

374

2411

(4200892) Spirometry reversibility

411

2682

1.58

16.07

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

374

2403

1.60

15.62

3.6

1.66

1.75

mmol/l

0.14

280

1767

(3019420) Tryptase [Mass/volume] in Serum or Plasma

149

3.52

15.50

1.5

1.6

6.96

10.37

ug/l

0.96

129

(3028026) IgM [Mass/volume] in Serum or Plasma

355

2262

1.61

15.34

1.8

1.9

1.36

1.31

g/l

0.18

324

2053

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1884

16045

1.28

14.96

2.1

1.9

94.26

95.18

pmol/l

0.37

1090

8431

(3017143) Hepatitis C virus Ab [Presence] in Serum

625

4519

1.44

14.87

1.8

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3981

37227

1.34

14.80

6.9

5.6

40.71

39.73

mmol/mol

8.17

3705

34566

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2206

19178

1.27

14.72

3.0

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

662

2.10

14.61

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

494

3436

1.49

14.36

7.3

6.9

1.37

1.35

mmol/l

0.15

482

3347

(3013512) EKG study

1403

11580

1.29

14.06

4.3

3.8

—

(3025941) Bacteria identified in Stool by Culture

338

2177

1.59

13.97

1.4

1.2

—

(40761511) CBC panel - Blood by Automated count

4472

42690

1.44

13.92

19.6

12.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

140

696

2.04

13.86

1.3

1.2

1.33

6.06

u/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

196

1095

1.82

13.71

1.4

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

210

1203

1.78

13.52

1.9

3.6

45.09

58.01

mg/l

0.50

146

981

(46235355) HIV 1 and 2 tests - Meaningful Use set

905

7061

1.34

13.52

1.9

1.8

—

(3044889) 12 lead EKG panel

3122

28430

1.26

13.43

4.5

3.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

339

2205

1.58

13.43

9.6

9.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

475

3325

1.47

13.35

3.4

2.9

211.23

195.92

ng/l

0.23

431

3035

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

6.31

13.27

1.1

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

209

1203

1.77

13.24

1.9

3.6

68.33

105.23

mg/l

0.36

146

982

(3018677) aPTT in Platelet poor plasma by Coagulation assay

807

6207

1.36

13.22

2.8

2.1

30.04

29.87

0.27

778

6034

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

138

696

2.01

13.15

3.9

2.9

—

(3000012) Reticulocyte production index

117

555

2.13

13.13

2.0

1.9

—

(3000991) Gas panel - Venous blood

466

3261

1.47

13.11

9.1

8.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

228

1353

1.72

12.98

2.3

2.2

5350.98

5292.75

u/l

0.01

535

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

203

1166

1.77

12.96

1.8

3.5

3.57

2.35

ratio

0.38

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

459

3212

1.47

12.91

2.8

2.6

62.20

66.74

ml/min/173m2

1.51

206

1257

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

484

3425

1.46

12.85

2.6

2.3

6.12

7.85

ug/l

1.21

432

3013

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

110

515

2.16

12.77

1.3

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

4.12

12.74

2.1

1.8

22.46

187.79

au/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

414

2846

1.50

12.73

4.8

3.8

104.32

90.98

ng/l

1.57

341

2446

(3042631) Mycobacterium sp identified in Specimen

112

532

2.13

12.55

2.1

2.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

161

871

1.88

12.50

2.6

2.2

131.01

129.14

g/l

0.43

138

621

(3004451) EKG impression Narrative

182

2.99

12.45

1.4

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

139

721

1.95

12.26

1.3

1.2

—

9.54

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

174

977

1.81

12.02

2.0

10.60

10.83

mg/l

0.11

160

901

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

874

6901

1.32

11.88

1.7

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

640

4832

1.37

11.71

10.9

6.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

173

980

1.79

11.61

4.9

4.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

163

3.03

11.58

1.7

208.32

147.22

umol/l

0.32

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

166

931

1.81

11.52

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

118

591

2.02

11.51

1.3

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

113

3.47

11.51

2.3

2.1

9.25

9.39

mg/l

0.06

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

108

525

2.08

11.43

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

160

890

1.82

11.41

1.9

1.6

12937.90

13011.86

e6/l

0.01

131

648

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

275

1771

1.58

11.39

1.5

1.7

1.52

1.54

g/l

0.08

228

1535

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

162

908

1.81

11.28

1.5

—

(44813793) Dust mix specific IgE antibody measurement

233

2.64

11.19

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

243

3724

0.63

10.73

1.6

1.7

—

(3023419) Bacteria identified in Sputum by Culture

112

569

1.99

10.54

2.1

2.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

314

2.34

10.45

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

125

666

1.90

10.24

1.5

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

344

2.26

10.11

1.6

1.3

19824.51

118568.60

e6/l

1.90

237

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

523

2.01

10.09

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

168

985

1.73

10.06

2.3

145.35

102.84

ug/min

0.39

611

(3004616) Nuclear Ab [Presence] in Serum

416

2.14

10.06

1.4

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

249

1614

1.57

10.06

2.0

1.9

38.03

39.07

u/l

0.34

229

1433

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

165

963

1.74

10.05

1.4

1.2

30.26

38.28

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

1424

12176

1.24

9.89

3.7

3.2

47.37

92.41

e6/l

2.12

1169

9338

(3030467) Casts [#/volume] in Urine by Automated count

1310

11104

1.24

9.86

3.7

3.1

0.40

0.44

e6/l

0.42

1082

8412

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

154

887

1.76

9.83

1.4

1.2

3.37

6.07

u/ml

0.96

149

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

153

880

1.76

9.81

1.4

1.2

10.18

6.12

u/ml

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1252

10564

1.25

9.81

1.8

1.6

1.39

1.38

mmol/l

0.36

997

8853

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

748

5936

1.31

9.66

1.8

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

762

0.26

9.63

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

109

567

1.94

9.62

2.7

2.8

465.00

1972.47

u/ml

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4127

39345

1.28

9.56

5.1

4.4

6.04

5.93

mmol/l

5.17

3759

35975

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

578

1.92

9.43

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

161

2.81

9.41

1.2

1.1

1636.02

1420.50

miu/ml

0.55

161

(3026250) Tacrolimus [Mass/volume] in Blood

161

2.81

9.41

35.9

33.8

7.28

7.59

ug/l

0.43

148

(3047352) Trisomy 18 risk [Likelihood] in Fetus

745

0.27

9.28

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4519

43647

1.35

9.24

13.8

9.9

26.65

26.82

u/l

0.21

4396

42100

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

7.27

9.19

1.0

4.39

0.36

u/ml

0.43

(3005033) Fetal Nuchal fold Thickness US

740

0.27

9.18

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

176

2.69

9.03

1.2

1.0

1.09

0.93

u/ml

0.07

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

348

2.17

9.03

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

100

517

1.95

9.01

1.1

2.26

1.10

u/ml

0.50

217

(3037756) Immunofixation for Serum or Plasma

134

766

1.77

8.82

1.3

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

172

1058

1.65

8.67

3.9

3.2

1.61

1.52

mg/l

0.75

154

970

(3034274) Bile acid [Moles/volume] in Serum --fasting

414

2.05

8.67

1.8

2.1

5.51

6.79

umol/l

0.39

293

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

309

2.22

8.63

1.4

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

111

604

1.86

8.59

3.5

3.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

254

2.34

8.50

2.3

2.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

501

1.93

8.44

7.6

6.8

11.71

11.83

mg/l

0.08

460

(3038515) Glucose [Moles/volume] in Venous blood

138

807

1.73

8.41

4.5

3.1

7.52

7.42

mmol/l

0.17

138

786

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

899

0.36

8.40

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

898

0.36

8.39

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1084

9140

1.24

8.36

4.7

3.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

896

0.36

8.35

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

894

0.36

8.31

1.4

—

(3021788) Differential panel - Synovial fluid

120

679

1.79

8.20

1.7

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

252

2.32

8.20

1.1

1.3

4.34

0.62

u/ml

1.15

129

(40768797) Stomach Pathology biopsy report

676

5407

1.29

8.16

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

142

846

1.70

8.10

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

113

631

1.81

8.08

3.5

3.3

1.02

1.60

1.01

103

554

(3000570) Elastase.pancreatic [Mass/mass] in Stool

175

1107

1.60

7.91

1.4

275.88

276.12

ug/g

0.00

104

627

(3030981) Hyaline casts [#/volume] in Urine by Automated count

297

2108

1.43

7.79

2.8

0.32

0.31

e6/l

0.04

287

2055

(36660697) Celiac disease serology panel - Serum

402

3005

1.37

7.78

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

9.40

7.77

1.0

0.46

1.74

u/ml

—

(3022145) Colonoscopy Study observation

557

4370

1.31

7.77

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

288

2039

1.44

7.66

2.5

2.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

852

7075

1.25

7.48

2.9

3.0

2.47

2.45

mmol/l

2.70

763

6193

(3036180) Methadone [Presence] in Urine

165

2.56

7.41

1.7

3.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

113

650

1.76

7.35

1.1

2.67

1.79

u/ml

0.35

300

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

921

7731

1.23

7.31

4.5

3.6

322.77

557.96

ng/l

0.93

704

6010

(36304419) Bacteria [Presence] in Urine

1249

10816

1.21

7.26

3.5

3.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

155

2.59

7.26

26.0

25.1

117.59

117.30

ug/l

0.01

124

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

162

2482

0.64

7.17

1.3

1.4

—

(3018095) Leukocytes [#/volume] in Urine

1598

14168

1.19

7.13

4.1

3.6

108.38

100.57

e6/l

0.10

1255

10007

(3002385) Erythrocyte distribution width [Ratio]

3716

35343

1.20

7.07

22.9

16.2

14.85

14.99

0.40

3662

34706

(3001019) Free T4 and TSH panel - Serum or Plasma

130

2083

0.61

7.02

1.8

1.7

—

(3041354) Potassium [Moles/volume] in Venous blood

491

1.85

6.99

3.1

2.3

4.13

4.07

mmol/l

0.54

484

(3035285) Chloride [Moles/volume] in Venous blood

491

1.85

6.99

3.1

2.3

106.68

105.45

mmol/l

1.47

484

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

2.51

6.99

3.9

3.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

108

624

1.75

6.94

1.5

1.6

0.70

0.80

g/l

0.63

476

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

436

1.90

6.90

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

121

723

1.69

6.89

1.8

1.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

7.52

6.89

1.0

0.03

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

878

1.62

6.85

1.5

—

(3011412) CD3 cells [#/volume] in Blood

341

2.01

6.78

2.3

2.4

0.94

1.14

e9/l

1.83

308

(21494755) Public health laboratory ask at order entry panel

293

3969

0.72

6.73

1.3

—

(3017732) Neutrophils [#/volume] in Blood

368

2778

1.35

6.71

3.9

2.8

4.98

4.87

e9/l

0.06

309

2264

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

7.16

6.69

1.0

0.06

0.02

u/ml

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

973

0.46

6.65

1.4

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

199

2.32

6.64

2.3

2.6

93.44

92.61

0.05

191

(1001926) Buprenorphine [Presence] in Urine by Screen method

169

1107

1.54

6.64

2.7

2.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

478

1.83

6.63

3.1

2.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.47

6.59

2.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.11

6.57

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

333

2.00

6.49

2.2

1.5

1.17

1.31

promille

0.33

255

(3028192) IgG subclass 2 [Mass/volume] in Serum

403

1.90

6.47

1.4

1.3

3.02

2.97

g/l

0.10

291

(4062490) Immunoglobulin typing, IgG

404

1.89

6.43

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4026

38675

1.21

6.42

4.5

3.9

1.36

1.29

mmol/l

5.89

3669

35544

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

154

2.48

6.33

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

451

1.83

6.25

1.1

4.33

1.93

u/ml

1.01

177

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

198

1362

1.47

6.18

3.2

0.33

0.34

u/ml

0.09

118

769

(3003888) Timothy IgE Ab [Units/volume] in Serum

571

1.73

6.16

1.1

5.22

4.31

u/ml

0.20

257

(3024139) IgG subclass 3 [Mass/volume] in Serum

403

1.87

6.15

1.4

1.3

0.49

0.42

g/l

0.77

289

(3016879) Cocaine [Presence] in Urine

193

1323

1.48

6.14

2.6

2.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

1193

1.50

6.12

1.3

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

404

1.87

6.11

1.4

1.3

6.82

6.85

g/l

0.03

289

(21494890) Protein electrophoresis panel - 24 hour Urine

390

1.88

6.10

1.4

2.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

528

1.76

6.10

2.4

2.5

13.31

13.16

0.94

522

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

105

2.77

6.04

1.3

1.4

34.75

33.04

0.08

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4176

40311

1.21

6.04

5.1

4.3

4.55

4.66

mmol/l

9.01

3847

37534

(3014599) Egg white IgE Ab [Units/volume] in Serum

177

2.33

5.98

1.0

0.58

0.48

u/ml

0.25

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

171

2.35

5.96

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

178

2.31

5.91

1.1

54.97

28.10

u/l

0.56

163

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

157

1040

1.53

5.90

1.1

1.88

7.73

u/ml

—

130

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

130

2.55

5.85

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.95

5.83

2.5

2.3

87.37

166.75

e6/l

1.39

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4242

41051

1.22

5.75

5.4

4.8

2.69

2.76

mmol/l

6.16

3889

38010

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

557

4537

1.26

5.75

1.6

1.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

556

4533

1.25

5.70

2.7

2.8

10.53

8.26

umol/l

0.95

458

3958

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

134

866

1.56

5.64

1.6

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

178

2.26

5.47

1.1

119.95

89.15

u/l

0.52

163

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

199

1405

1.43

5.47

1.6

1.7

—

(3011288) Drugs identified in Urine by Screen method

144

954

1.52

5.44

3.6

3.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

2.04

5.43

1.3

1.5

—

(3016750) Collection duration of Urine

239

2.06

5.35

2.3

2.1

478.31

488.93

min

0.31

176

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

219

2.11

5.34

1.2

1.6

4.73

7.11

u/l

1.91

186

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

402

1.80

5.29

1.3

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

9.11

5.28

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

582

1.66

5.27

1.6

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4138

40023

1.19

5.26

4.8

4.3

1.42

1.45

mmol/l

5.13

3787

37070

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

221

2.09

5.23

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

202

1445

1.41

5.18

2.6

2.2

—

(3003181) Sodium [Moles/volume] in Urine

103

640

1.62

5.15

1.4

61.60

64.67

mmol/l

0.29

511

(3021879) Hepatitis B virus core Ab [Presence] in Serum

374

2942

1.29

5.15

1.4

—

(3027008) Opiates [Presence] in Urine

201

1439

1.41

5.13

2.6

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

200

1431

1.41

5.12

2.6

2.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

4.85

5.11

1.1

1.0

0.01

0.05

u/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

429

1.76

5.10

2.5

2.4

1.33

1.32

g/24h

0.01

213

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

717

8403

0.83

5.06

2.9

3.0

0.77

ug/l

0.00

473

5595

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

219

2.06

4.96

1.4

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

6.01

4.90

1.0

0.80

0.01

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

131

2.37

4.80

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

119

2.45

4.78

1.3

1.2

38.72

39.25

g/l

0.07

(3035637) Corticotropin [Mass/volume] in Plasma

468

1.70

4.77

1.3

1.5

—

(3008295) Osmolality of Serum or Plasma

401

1.76

4.76

1.4

280.60

279.72

mosm/kgh2o

0.12

316

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

439

1.72

4.73

1.6

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

439

1.72

4.73

1.6

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.61

4.72

1.0

13.66

10.34

u/ml

0.23

(3004775) Volume in Urine collected for unspecified duration

330

1.83

4.67

2.4

2.2

689.41

632.79

0.45

214

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

714

1.55

4.62

1.5

1.2

74.82

37.57

u/ml

0.85

(3007566) Smooth muscle Ab [Titer] in Serum

156

1091

1.44

4.57

1.3

1.2

122.43

116.32

titre

0.05

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

513

1.65

4.54

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

10.01

4.51

2.1

3.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

189

1372

1.39

4.50

1.8

1.6

350.59

297.23

mu/l

0.69

173

1237

(3027944) Amphetamines [Presence] in Urine

194

1416

1.38

4.47

2.6

2.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

439

1.70

4.47

4.8

20.7

7.87

7.35

mmol/l

0.59

368

(3034770) Mitochondria Ab [Titer] in Serum

155

1088

1.44

4.46

1.3

1.2

857.78

1137.50

titre

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

149

2.22

4.42

2.8

2.3

126.52

156.09

nmol/l

1.09

131

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

223

1668

1.35

4.42

2.1

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

564

1.61

4.40

5.2

5.1

388.96

363.43

umol/l

0.94

483

(3009542) Hematocrit [Volume Fraction] of Blood

4654

45668

1.26

4.39

30.1

19.9

39.72

40.38

4.92

4217

42799

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

301

1.84

4.37

1.2

1.3

2.03

2.05

mmol/l

0.08

282

(3008401) Mugwort IgE Ab [Units/volume] in Serum

550

1.61

4.36

1.1

0.83

0.79

u/ml

0.03

193

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

224

1.97

4.34

2.1

2.6

0.20

0.21

e9/l

0.17

194

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.89

4.32

1.4

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

153

1079

1.43

4.31

1.3

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

138

2.25

4.30

2.0

2.3

709.92

641.60

e6/l

0.10

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

369

1.74

4.29

1.3

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

101

2.48

4.29

1.3

1.6

14.28

12.49

g/l

0.36

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

632

1.56

4.26

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

632

1.56

4.26

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

206

1532

1.36

4.25

1.9

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

146

2.20

4.20

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

372

1.73

4.18

1.1

1.2

71.31

61.77

u/l

0.24

336

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

245

1878

1.32

4.13

6.0

4.0

24.02

24.17

mmol/l

0.31

237

1842

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

315

1.79

4.10

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

315

1.79

4.10

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

315

1.79

4.10

1.3

1.5

—

(3017704) Immunofixation for Urine

215

1.96

4.10

1.3

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.51

4.04

2.4

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

303

2398

1.28

4.03

1.3

36.02

55.73

au/ml

1.27

136

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

202

1513

1.35

4.00

1.1

0.88

2.04

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

4657

45751

1.25

3.98

30.2

19.9

134.09

135.94

g/l

13.57

4601

45114

(3007461) Platelets [#/volume] in Blood

4653

45709

1.25

3.97

30.0

19.9

256.68

249.41

e9/l

10.46

4589

44557

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

119

2.28

3.86

2.3

2.1

—

(3024731) MCV [Entitic volume]

4654

45735

1.24

3.85

29.9

19.8

91.28

90.96

4.90

4600

45106

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

111

754

1.48

3.84

1.7

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

4654

45738

1.24

3.83

30.0

19.8

4.44

4.51

e12/l

14.96

4577

44466

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

126

2.23

3.82

1.1

1.0

—

(3022313) Gas panel - Capillary blood

237

1830

1.31

3.82

3.9

3.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

235

1.88

3.82

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

151

1088

1.40

3.81

1.3

1.1

—

(3035941) MCH [Entitic mass]

4653

45730

1.24

3.81

29.8

19.7

30.38

30.32

1.50

4600

45098

(3010813) Leukocytes [#/volume] in Blood

4653

45736

1.24

3.76

30.0

19.8

7.13

6.70

e9/l

23.93

4574

44447

(3023430) Cat dander IgE Ab [Units/volume] in Serum

415

1.65

3.75

1.1

7.61

2.87

u/ml

0.83

133

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.40

3.72

1.1

—

(4034850) Laboratory test

175

1298

1.36

3.72

10.3

9.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

151

1094

1.39

3.70

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

550

1.55

3.70

1.1

1.56

1.53

g/l

0.33

496

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.79

3.68

1.2

1.3

94.50

535.63

u/l

0.47

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1465

1.34

3.67

1.8

2.4

3.97

3.66

g/l

1.34

176

1332

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1465

1.34

3.67

1.8

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

135

2.15

3.66

1.6

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1467

1.34

3.64

1.8

2.4

7.60

7.41

g/l

0.85

176

1333

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

388

1.66

3.63

1.0

1.1

—

31.12

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

232

1.86

3.63

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

233

1.85

3.59

2.1

2.5

481.73

487.52

e6/l

0.03

195

(3014148) Varicella zoster virus Ab [Titer] in Serum

483

1.58

3.58

1.1

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

321

2599

1.25

3.57

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

117

2.23

3.57

2.5

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

185

1.95

3.52

1.0

1.1

99.93

92.43

0.69

146

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

105

2.29

3.51

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

10.01

3.49

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.37

3.47

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

2.17

3.47

1.9

2.1

1784.62

4411.65

e6/l

0.77

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

139

2.09

3.42

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.35

3.40

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.51

3.37

1.2

1.37

1.69

mmol/l

0.47

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

883

0.61

3.36

1.9

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

148

2.03

3.30

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.42

3.30

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

263

1.76

3.26

1.4

1.5

74.87

84.86

umol/l

1.30

263

(3033799) Differential panel - Peritoneal fluid

122

2.14

3.25

2.7

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

180

1372

1.32

3.24

1.6

2.4

10.15

g/l

0.00

161

1227

(3023199) Leukocytes [#/volume] in Pleural fluid

489

1.54

3.20

1.5

1.4

2374.81

2153.87

e6/l

0.12

351

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

235

1.79

3.20

1.1

1.03

1.05

ratio

0.70

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.54

3.19

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.17

3.19

2.6

1.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.27

3.19

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

298

2428

1.24

3.16

3.1

3.3

4.30

4.49

pmol/l

2.85

262

2157

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

104

2.22

3.15

1.5

1.2

—

(40768446) Kidney Pathology biopsy report

144

2.02

3.14

1.8

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

2.33

3.07

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.33

3.07

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.33

3.07

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.33

3.07

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

376

1.60

3.05

2.8

2.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

479

0.50

3.03

1.6

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

154

1162

1.34

2.99

3.1

2.6

3.69

3.55

g/l

0.49

142

1100

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

113

813

1.40

2.96

3.1

1.9

0.83

0.84

nmol/l

0.02

687

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

107

2.15

2.96

1.4

1.2

0.31

0.30

g/l

0.19

(3027456) Digoxin [Moles/volume] in Serum or Plasma

100

705

1.43

2.94

3.2

3.0

0.84

0.82

nmol/l

0.19

535

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

155

1.94

2.94

1.3

1.1

180.82

193.64

iu/ml

0.14

155

(3000492) Spirometry study

453

3876

1.19

2.93

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

673

5942

1.15

2.93

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

319

2645

1.22

2.89

2.5

2.4

14.60

23.19

au/ml

1.41

196

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.70

2.88

1.4

1.3

755561.04

192690.61

nmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

836

0.63

2.88

1.4

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

6.67

2.86

1.0

—

(3000330) Specific gravity of Urine by Test strip

248

2004

1.25

2.86

4.9

3.2

—

(3028433) Virus identified in Specimen by Culture

122

2.05

2.86

1.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

407

1.55

2.84

1.0

1.1

—

2.72

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

161

1234

1.31

2.83

2.7

2.3

91.19

90.93

0.05

156

1190

(3052592) Norovirus Ag [Presence] in Stool

2.40

2.79

1.4

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.55

2.78

4.5

7.0

—

(40758558) Short blood count panel - Blood

1098

10037

1.12

2.78

8.4

6.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

490

1.50

2.77

1.1

1.4

349.86

363.51

pmol/l

0.07

426

(3016038) Potassium [Moles/volume] in Urine

254

1.70

2.77

1.0

1.2

30.24

35.91

mmol/l

1.23

220

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

217

1.76

2.75

1.2

1.6

9.42

6.66

u/l

0.37

177

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

566

1.46

2.72

1.4

1.3

7.03

7.33

mmol/l

0.50

512

(3017509) Phencyclidine [Presence] in Urine

3.24

2.72

1.0

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

436

1.52

2.71

1.5

1.4

36552.07

72386.71

e6/l

0.80

250

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.43

2.70

1.3

0.29

1.88

mmol/l

—

(3008898) HLA-B27 [Presence]

171

1333

1.29

2.67

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.75

2.67

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

197

1564

1.27

2.67

4.2

3.9

24.74

24.81

mmol/l

0.10

181

1450

(3024263) Appearance of Synovial fluid

212

1.75

2.66

1.6

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

265

1.67

2.65

1.3

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.15

2.64

2.5

2.4

0.73

0.57

u/field

0.16

(3000093) Morphology [Interpretation] in Blood Narrative

359

1.57

2.63

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

191

1.79

2.61

3.2

3.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

104

756

1.38

2.61

1.5

1.2

257.43

275.86

u/ml

0.27

486

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

4.00

2.56

2.7

2.0

3.45

2.56

mg/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.00

2.56

2.5

2.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

354

1.56

2.55

1.3

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

566

1.44

2.54

1.4

1.3

0.24

0.34

nmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.73

2.54

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1364

1.28

2.50

1.9

2.4

2.89

3.00

g/l

0.73

155

1231

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

109

805

1.36

2.50

1.4

1.2

—

(3024928) Oxygen saturation in Venous blood

114

848

1.35

2.49

5.3

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

240

1966

1.23

2.49

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

470

1.47

2.48

2.2

2.0

22.48

22.87

mg/l

0.03

110

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

653

1.40

2.48

1.1

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.47

2.48

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.38

2.47

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

116

867

1.35

2.46

1.3

3.82

3.79

mmol/l

0.13

108

806

(3019977) pH of Arterial blood

233

1.68

2.44

3.1

2.6

7.42

0.12

(3023511) Choriogonadotropin [Units/volume] in Urine

672

1.39

2.44

1.7

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

1.73

2.44

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

2.42

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

143

1105

1.30

2.42

1.4

9.97

9.92

u/l

0.02

117

899

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

432

1.49

2.41

2.3

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

138

1.89

2.40

1.5

1.4

15.67

15.54

pmol/l

0.03

116

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

242

1.66

2.40

1.4

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.12

2.36

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

181

1448

1.26

2.34

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

435

3785

1.16

2.34

2.0

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

395

1.50

2.32

1.4

6.34

6.31

mmol/l

0.02

367

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

257

2139

1.21

2.31

9.5

9.2

24.13

24.26

mmol/l

0.27

244

2078

(3045788) Cell count panel - Pleural fluid

388

1.50

2.30

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

496

1.44

2.27

1.5

1.3

—

nmol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

128

984

1.31

2.27

1.3

757.74

523.99

mg/l

0.66

122

927

(3035880) pH of Pleural fluid

223

1.66

2.27

1.4

1.3

—

(3036048) Francisella tularensis Ab [Titer] in Serum

2.07

2.26

1.3

1.2

—

184.00

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

209

1707

1.23

2.26

1.3

1.4

27.34

28.25

iu/l

0.14

176

1458

(3017354) Segmented neutrophils/100 leukocytes in Blood

398

1.49

2.25

2.6

3.1

55.08

57.79

0.37

334

(3019832) Treponema pallidum Ab [Presence] in Serum

413

3594

1.16

2.23

1.8

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

225

1.65

2.20

2.7

39.20

40.97

0.36

128

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

106

800

1.33

2.15

1.7

1.4

10.68

14.10

u/ml

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.29

2.15

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

723

1.35

2.14

1.8

1.4

108.14

120.40

u/ml

0.74

162

(40762365) Oxygen content in Arterial blood by calculation

2.17

2.14

2.8

2.2

14.84

15.00

ml/dl

0.07

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

100

749

1.34

2.14

1.9

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.62

2.14

1.0

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

656

1.36

2.11

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

113

1464

0.77

2.10

1.7

5.81

3.41

mg/l

0.81

1061

(3009015) Lactate [Moles/volume] in Synovial fluid

2.56

2.07

1.4

1.3

8.26

5.56

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.56

2.07

1.5

1.8

—

(3042733) HLA Ab [Presence] in Serum

131

1.84

2.07

4.4

4.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.71

2.06

1.1

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

269

1.57

2.05

1.5

1.1

—

27.24

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.03

2.05

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1073

0.73

2.05

2.6

2.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

199

1.66

2.04

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

238

1.60

2.04

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.40

2.02

1.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

105

801

1.32

2.00

1.8

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

1.1

—

(3037121) Protein [Mass/volume] in Urine

170

1379

1.24

1.99

3.5

3.0

0.40

0.32

g/l

0.49

579

(3006653) Thiamine [Moles/volume] in Blood

201

1.65

1.98

1.5

1.2

139.35

136.59

nmol/l

0.13

201

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

148

1.76

1.98

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

469

1.41

1.97

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

486

1.40

1.96

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

520

1.39

1.96

1.4

26.22

27.37

u/l

0.11

432

(3044640) Blood type and Crossmatch panel - Blood

1372

12890

1.09

1.95

3.0

2.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

204

0.44

1.94

1.1

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

149

1.75

1.94

2.5

2.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.57

1.94

1.1

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

479

1.40

1.93

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

268

0.48

1.91

1.2

1.3

1.51

1.57

g/l

0.38

268

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

514

1.39

1.91

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

472

1.40

1.91

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

106

1.89

1.90

1.1

97.80

91.20

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

473

1.40

1.89

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

103

792

1.31

1.88

1.2

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.18

1.88

2.0

3.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

114

1.85

1.86

2.0

1.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.86

1.86

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

1.85

0.0

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

3.53

1.83

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

269

1.53

1.83

1.4

12.56

12.94

u/l

0.17

259

(3020911) Cortisol [Moles/time] in 24 hour Urine

115

1.83

1.82

1.3

69.29

136.79

nmol/24h

0.63

115

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

478

1.39

1.79

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.76

1.79

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

215

1.59

1.79

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.34

1.77

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

651

1.33

1.77

1.5

—

(3017569) Oxygen content in Arterial blood

208

1.59

1.76

2.8

2.3

—

(3016228) CD19 cells/100 cells in Blood

154

1.69

1.75

2.5

2.1

6.42

9.61

1.31

149

(3001729) Color of Synovial fluid

2.50

1.74

2.1

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

102

794

1.29

1.72

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

102

794

1.29

1.72

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

768

1.29

1.72

1.6

1.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

542

1.35

1.72

1.9

2.2

—

4.08

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

471

4221

1.13

1.71

2.1

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

163

1.66

1.71

3.0

2.8

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

577

1.34

1.71

1.1

120.45

114.69

0.98

525

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

432

1.39

1.70

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

733

6734

1.10

1.70

3.1

2.7

1.36

1.18

e6/l

0.54

477

3789

(3018133) Calcium [Moles/volume] in Urine

2.18

1.67

1.2

2.1

2.70

2.67

mmol/l

0.01

(3003327) Ova and parasites identified in Stool by Light microscopy

146

1194

1.23

1.64

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.44

1.64

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

1.77

1.60

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

455

1.37

1.59

2.2

2.4

—

(3036489) Thrombin time

178

1491

1.20

1.59

2.6

2.1

21.13

21.56

0.56

144

1296

(3045683) HLA typing for celiac disease panel - Blood or Tissue

214

1.55

1.59

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

106

1.80

1.58

1.1

1.2

100.89

89.25

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

271

1.48

1.58

1.1

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

—

30.20

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

296

1.46

1.57

1.8

1.5

—

(40768441) Liver Pathology biopsy report

288

1.46

1.57

1.3

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.20

1.56

1.0

1.2

—

(1002224) Polysomnography panel

137

1666

0.82

1.56

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

107

1.78

1.54

1.2

118.36

107.57

0.77

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.03

1.54

1.1

96.85

98.22

0.06

(3010838) Calcium [Moles/time] in 24 hour Urine

677

1.29

1.51

2.0

5.26

5.07

mmol/24h

0.18

594

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

267

2325

1.16

1.51

1.9

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

230

1982

1.17

1.49

1.1

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

215

1843

1.17

1.49

2.2

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

226

1.51

1.48

1.2

1.1

—

(21494434) Karyotype in Bone marrow

342

1.41

1.48

1.2

—

(3012441) Differential panel - Pleural fluid

419

1.36

1.47

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

147

1220

1.21

1.47

1.4

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

442

4889

0.89

1.46

4.6

4.5

31.17

32.20

1.26

309

3381

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.12

1.44

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.12

1.44

3.7

2.3

—

22.09

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

294

1.43

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.04

1.43

1.2

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

165

1.58

1.40

1.0

0.49

0.19

u/ml

0.53

(3022493) Free Hemoglobin [Mass/volume] in Plasma

165

1.58

1.40

6.1

5.7

68.40

62.14

mg/l

0.17

117

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2668

25913

1.06

1.39

3.0

2.9

—

(3026480) Teichoate Ab [Titer] in Serum

2.42

1.39

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

460

4181

1.11

1.35

3.6

4.2

18.23

24.29

ug/l

0.42

381

3382

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

1.33

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

208

1.49

1.32

1.2

1.7

—

(3025130) Human papilloma virus identified in Specimen

499

0.70

1.31

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

359

1.37

1.31

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

148

1245

1.19

1.31

2.2

2.5

0.90

1.01

g/l

0.12

122

1072

(3035320) C reactive protein [Mass/volume] in Body fluid

283

0.60

1.31

6.1

2.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.09

1.30

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

106

1.70

1.29

1.4

1.2

67.17

171.53

ug/l

0.61

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.78

1.28

1.6

1.2

—

1.08

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

641

1.27

1.28

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

122

1.64

1.27

6.8

4.1

49.75

55.76

0.50

117

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.05

1.26

1.4

1.2

—

(3020650) Glucose [Presence] in Urine

107

1.68

1.25

1.3

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

106

869

1.22

1.24

1.4

44.41

23.04

e6/l

0.34

671

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

106

869

1.22

1.24

1.4

2309.08

1156.28

e6/l

0.37

708

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

295

1.39

1.24

1.2

1.1

29.98

44.14

mg/l

3.38

241

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

591

1.27

1.23

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.63

1.21

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.80

1.21

6.9

6.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

294

2626

1.13

1.20

1.2

106.43

141.85

iu/ml

1.19

103

936

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

383

1.33

1.19

1.1

1.0

0.09

0.12

u/ml

0.31

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

250

0.60

1.18

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

109

1.65

1.18

1.3

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

1137

0.81

1.18

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

173

1.51

1.17

1.1

1.2

168.83

165.07

mmol/24h

0.05

173

(3006922) Hepatitis E virus Ab [Presence] in Serum

273

1.39

1.17

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

102

839

1.22

1.17

1.7

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

404

0.69

1.15

1.3

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.15

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

110

1.64

1.15

9.2

7.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

121

1015

1.20

1.14

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

439

1.30

1.13

1.5

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

387

1.32

1.13

3.9

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

644

1.25

1.12

1.1

161.91

15621.52

iu/ml

0.53

150

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

159

1.51

1.11

1.0

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

209

1.44

1.10

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

141

1204

1.18

1.10

1.4

1.3

201.56

220.55

miu/ml

0.24

563

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

802

1.21

1.08

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

541

1.26

1.07

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.65

1.06

9.7

7.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

253

1.39

1.06

1.1

1.0

—

(3048879) Bone marrow aspiration report

113

1.60

1.05

1.3

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

121

1.57

1.05

1.8

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

254

1.38

1.04

1.1

1.0

—

(4146454) Self-monitoring of blood glucose

441

0.72

1.04

3.2

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

1.03

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

147

1700

0.86

1.03

1.6

1.5

—

(3044927) Protein electrophoresis panel - Urine

393

1.30

1.03

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

402

1.30

1.03

2.3

3.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

196

1.43

1.02

2.1

1.6

1.49

2.70

u/field

0.85

141

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.77

1.00

2.3

1.9

15.95

17.20

umol/l

0.18

(3024932) HLA-DR beta [Type]

131

1.53

0.99

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.97

0.0

1.3

—

(3042517) Benzodiazepines panel - Urine

1.95

0.97

1.4

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

593

0.77

0.96

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1131

0.84

0.96

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

129

1109

1.17

0.96

3.5

2.6

197.60

191.48

0.30

121

1059

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

199

1.41

0.95

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

591

0.78

0.94

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

141

1.49

0.94

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

0.94

1.3

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

651

1.22

0.94

1.7

1.6

—

(3023410) Appearance of Cerebral spinal fluid

386

0.72

0.93

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1024

9774

1.06

0.93

3.1

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

555

0.77

0.92

1.5

0.16

0.40

nmol/l

4.90

441

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

167

1.44

0.91

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.14

0.91

1.7

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

124

1068

1.17

0.91

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

127

1096

1.16

0.91

1.7

2.4

0.05

0.03

g/l

0.24

114

1004

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

279

0.68

0.90

1.8

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.91

0.88

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.79

0.87

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

924

0.83

0.87

1.1

1.2

—

(3019174) dRVVT (LA screen)

2.00

0.87

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

307

1.31

0.87

1.2

—

275.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

307

1.31

0.87

1.2

290.00

164.83

titre

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

101

860

1.18

0.86

2.4

3.6

249.30

810.57

u/ml

0.93

786

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

136

1.47

0.86

2.9

1.8

307.40

26375.58

u/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

1.72

0.86

2.7

7.2

—

(3016018) Differential panel - Cerebral spinal fluid

407

1.26

0.83

1.1

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

257

1.33

0.82

1.4

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

114

0.53

0.82

2.5

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

284

1.31

0.81

1.1

245.29

277.13

mg/l

0.74

244

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.55

0.81

3.1

7.9

69.30

72.53

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.70

0.80

4.5

6.5

—

(3003338) MCHC [Mass/volume]

3456

35041

0.96

0.79

26.6

17.2

332.39

332.66

g/l

0.98

3429

34788

(40768804) Tissue Pathology biopsy report

1681

16321

1.05

0.78

2.1

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.56

0.78

1.4

3.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.59

0.78

1.0

1.1

—

(3019225) pH of Specimen

419

3912

1.08

0.76

4.4

4.3

—

(3024471) HLA-A [Type]

132

1.44

0.75

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

290

0.72

0.74

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

324

1.27

0.74

1.3

—

titre

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1137

1.14

0.73

1.6

2.3

37.64

37.67

g/l

0.02

111

1002

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.00

0.72

1.2

1.1

—

6.94

u/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.00

0.72

1.6

1.8

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.80

0.72

1.0

—

(3045424) Erythrocytes [Presence] in Urine

692

1.17

0.70

1.6

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.92

0.70

2.2

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

473

1.21

0.68

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

255

2347

1.09

0.68

2.2

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

887

0.85

0.67

3.9

3.3

27.12

26.73

mg/l

0.03

551

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.63

0.66

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

285

1.27

0.66

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

989

10261

0.95

0.65

5.2

3.9

86.93

89.50

2.43

951

10018

(3032057) Clostridioides difficile [Presence] in Stool

1.54

0.65

2.0

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1494

14524

1.04

0.65

4.5

4.9

2.00

3.53

ug/l

3.59

1333

13042

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

551

1.18

0.64

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.50

0.63

2.8

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

607

6364

0.95

0.62

3.4

2.9

3.77

2.27

e6/l

1.16

357

3443

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.67

0.61

14.4

8.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

210

0.71

0.60

2.7

2.0

67.67

257.08

ug/min

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

398

1.21

0.60

2.2

2.3

—

(3051593) INR in Capillary blood by Coagulation assay

200

1.30

0.60

16.5

11.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

218

1.29

0.60

1.1

77.47

89.11

u/l

0.41

188

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

659

1.16

0.58

1.2

1.3

30.32

33.67

u/l

0.12

571

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

175

1.32

0.58

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

175

1.32

0.58

1.5

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

351

3729

0.94

0.57

2.9

2.3

37.84

52.18

u/l

0.56

307

3214

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

160

1457

1.10

0.56

2.6

3.6

562.56

2903.26

u/ml

0.68

143

1241

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.56

1.0

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.51

0.56

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

393

1.20

0.55

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.45

0.55

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

880

1.13

0.54

1.8

1.9

209.46

199.12

pmol/l

0.48

823

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

598

1.16

0.54

1.3

1.2

1.47

3.99

u/ml

2.63

189

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.58

0.54

1.2

1.5

56.50

45.66

umol/l

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.50

0.54

2.3

2.2

64.37

77.11

pmol/l

—

(3000034) Microalbumin [Mass/volume] in Urine

405

1.19

0.52

3.1

3.0

40.37

35.78

mg/l

0.08

297

(3047189) Immunofixation for 24 hour Urine

187

1.28

0.52

1.3

1.8

—

(40757373) Influenza virus identified in Isolate

1.45

0.51

2.3

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.50

0.51

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate

197

1.27

0.51

1.1

1.2

—

(4035726) Immunohistochemistry procedure

373

3533

1.06

0.50

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

1.27

0.49

1.2

—

(3020491) Glucose [Moles/volume] in Blood

312

0.80

0.48

2.2

1.7

7.93

6.67

mmol/l

1.33

212

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

1.37

0.47

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.47

0.47

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

300

1.20

0.46

2.1

3.76

1.91

u/field

0.90

118

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

227

1.23

0.46

1.5

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

199

0.75

0.46

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

121

0.66

0.45

3.1

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

210

1.24

0.45

1.1

1.2

21.11

21.93

u/l

0.04

177

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

139

1277

1.09

0.44

1.5

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.44

2.7

1.9

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.37

0.43

1.1

1.2

887.38

296.66

pmol/l

—

(3005570) Glucose [Moles/volume] in Urine

405

1.16

0.43

3.2

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

140

1.29

0.41

1.1

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.41

1.1

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.41

1.1

1.6

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.41

0.0

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.36

0.41

2.9

1.9

55.11

33.87

pmol/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1506

14767

1.03

0.40

3.4

2.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

10.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

241

1.20

0.40

1.2

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

521

1.13

0.40

1.2

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.43

0.39

1.4

1.2

—

(3013762) Body weight Measured

0.00

0.39

0.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.36

0.38

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.39

0.38

2.4

2.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

580

1.12

0.38

1.3

1.2

2.42

4.81

u/ml

2.14

246

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

130

1203

1.08

0.37

1.7

1.8

39.66

41.38

nmol/l

0.41

125

1162

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1139

11645

0.97

0.37

4.3

4.2

22.79

21.84

1.15

536

5698

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

179

1.23

0.37

4.4

3.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.35

0.37

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

322

0.84

0.37

1.5

0.90

0.97

g/l

1.10

322

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

111

1022

1.09

0.36

1.5

2.4

0.00

g/l

-0.00

936

(3049717) Cytology report of Urine Cyto stain

169

1584

1.07

0.36

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

660

1.11

0.35

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.36

0.34

1.0

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.36

0.34

1.0

1.3

1.99

1.72

umol/24h

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

949

1.09

0.34

1.8

1.9

4.41

4.63

iu/l

0.06

338

(3051611) Lipemic interference index of Serum or Plasma

403

0.87

0.33

4.8

3.2

—

(3022621) pH of Urine by Test strip

278

2656

1.05

0.32

3.9

2.8

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.28

0.32

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.28

0.32

1.2

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3876

38533

1.03

0.32

17.9

12.8

82.57

81.67

ml/min/173m2

1.59

3345

31807

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

128

1.25

0.31

1.5

1.8

—

(37021550) Renin [Units/volume] in Plasma --upright

1.31

0.31

1.0

1.3

114.96

61.13

mu/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

276

1.16

0.31

1.6

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

1012

1.08

0.31

1.6

2.4

0.00

g/l

-0.00

936

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.32

0.30

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

184

1.20

0.30

1.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

184

1.20

0.30

1.1

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

378

0.87

0.30

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.27

0.30

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.28

0.28

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

149

1.21

0.27

1.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

149

1.21

0.27

1.2

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

150

1.20

0.26

1.2

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.28

0.26

1.0

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

256

0.86

0.25

3.7

7.2

—

(3045414) Leukocytes [Presence] in Urine

175

1834

0.95

0.24

1.9

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.32

0.23

1.8

2.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

411

0.90

0.23

1.1

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.27

0.22

1.9

2.78

1.97

ug/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.22

0.22

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

283

0.88

0.21

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

283

0.88

0.21

1.3

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.24

0.21

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

117

1.20

0.20

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.20

0.0

1.4

—

1.36

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

355

0.90

0.20

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.22

0.20

3.7

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

0.81

0.20

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1144

11590

0.98

0.19

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

280

0.89

0.18

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

280

0.89

0.18

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

185

0.86

0.18

3.3

3.2

—

(40768793) Breast Pathology biopsy report

825

0.94

0.17

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.11

0.17

1.3

1.8

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

205

1.12

0.17

6.1

46.20

12952.02

u/ml

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.16

0.16

1.6

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

200

1938

1.03

0.16

3.1

3.4

70.69

57.54

u/ml

0.32

195

1868

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

368

3762

0.98

0.16

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.13

0.15

1.0

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

410

1.07

0.15

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

388

0.93

0.14

2.7

5.3

409.41

54.19

u/ml

—

117

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

283

0.92

0.12

1.3

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

219

1.10

0.12

1.0

1.1

0.93

1.11

u/l

2.71

104

(3006270) Folate [Moles/volume] in Blood

336

1.07

0.12

1.1

367.42

376.82

nmol/l

0.09

295

(3051651) Icteric interference index of Serum or Plasma

239

1.09

0.12

5.7

3.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

280

0.93

0.10

1.3

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

280

0.93

0.10

1.0

40.71

45.20

ng/l

0.20

188

(3014271) Vancomycin [Susceptibility]

193

1.09

0.10

3.3

2.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

330

3249

1.02

0.09

2.3

2.2

11.92

12.66

nmol/l

0.92

287

2886

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

279

0.93

0.09

1.0

782.71

708.66

ng/l

0.46

187

(40768795) Lymph node Pathology biopsy report

379

1.06

0.09

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

145

1.10

0.09

3.1

2.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

107

1.12

0.08

2.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.77

0.08

1.0

85.46

74.53

ug/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.04

0.08

1.0

1.3

—

119.00

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

976

0.97

0.07

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.82

0.07

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

276

0.94

0.07

1.0

280.88

323.31

ng/l

0.41

190

(3024891) Influenza virus A+B Ag [Presence] in Specimen

102

996

1.02

0.07

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

178

1.07

0.05

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

178

1.07

0.05

1.3

1.4

—

(3002256) Pathology report gross observation

534

5376

0.99

0.05

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

161

0.93

0.05

2.7

2.2

—

(3045142) Bone marrow Pathology biopsy report

426

1.03

0.05

1.3

—

(3022689) Creatine [Moles/volume] in Urine

120

0.92

0.05

1.3

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

536

1.03

0.04

1.1

9.56

3.45

u/ml

0.54

255

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

1194

1.01

0.03

1.4

1.3

—

(3034426) Prothrombin time (PT)

139

0.94

0.03

1.3

1.2

—

(3011648) Oxygen content in Venous blood

330

0.97

0.03

3.9

2.3

10.07

11.25

0.85

330

(3025018) Bordetella pertussis Ab [Titer] in Serum

229

0.96

0.02

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

120

1189

1.01

0.02

3.6

3.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

303

1.02

0.01

1.4

165.38

197.53

pmol/l

0.44

303

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

104

1.06

0.01

1.5

2.8

—

(3003129) Base excess in Capillary blood by calculation

104

1.06

0.01

1.4

1.8

-0.52

0.94

mmol/l

0.83

(40765089) Chromosome analysis panel - Blood by G-banded

114

1.05

0.00

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

0.98

0.00

3.6

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

122

0.98

0.00

3.6

2.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

135

0.96

0.00

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

217

1.01

0.00

2.5

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

229

1.00

0.00

1.6

1.5

—

(3014891) Appearance of Pleural fluid

0.86

-0.00

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.93

-0.00

3.0

3.5

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

67.68

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.91

-0.00

1.4

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.04

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.20

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_DERM and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.469 [1.34, 1.61]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.014

During the follow-up period (1.1.1998 — 31.12.2019), 2882 out of 16388 females with L12_INFECT_DERM died.

Males

Parameter	HR [95% CI]	p-value
L12_INFECT_DERM	1.857 [1.71, 2.02]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.05

During the follow-up period (1.1.1998 — 31.12.2019), 4766 out of 17856 males with L12_INFECT_DERM died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_DERM.

N-year risk	Females	Males
1	0.141%	0.336%
5	0.862%	2.178%
10	1.864%	6.076%
15	3.692%	11.038%
20	6.611%	18.34%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_DERM – Infective dermatitis

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Infective dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints